{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 29,
   "id": "a0a68102",
   "metadata": {},
   "outputs": [],
   "source": [
    "import pandas as pd\n",
    "import glob"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 30,
   "id": "f26f4f9d",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Abbreviation</th>\n",
       "      <th>Synonyms</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>11DEOXY</td>\n",
       "      <td>[11 deoxycortisol, Cortodoxin, Deoxycorticoste...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>17OHP</td>\n",
       "      <td>[17 hydroxyprogesterone, 17-Hydroxyprogesteron...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>ACACT</td>\n",
       "      <td>[acetoacetate, AcAc, Acetoacetic Acid, Diaceti...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>ALT</td>\n",
       "      <td>[alanine transaminase, SGPT, Serum Glutamate P...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>ALB</td>\n",
       "      <td>[albumin, Serum Albumin, Human Albumin, Plasma...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>254</th>\n",
       "      <td>PDW</td>\n",
       "      <td>[Platelet Distribution Width, Platelet Width, ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>255</th>\n",
       "      <td>TFT-R</td>\n",
       "      <td>[Thyroid Function Test - Reflex, Thyroid Funct...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>256</th>\n",
       "      <td>TFT</td>\n",
       "      <td>[Thyroid Function Test, Thyroid Function Panel...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>257</th>\n",
       "      <td>TPOAb</td>\n",
       "      <td>[Thyroid Peroxidase Antibodies, Anti-Thyroid P...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>258</th>\n",
       "      <td>TgAb</td>\n",
       "      <td>[Thyroglobulin Antibodies, Anti-Thyroglobulin ...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>259 rows × 2 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "    Abbreviation                                           Synonyms\n",
       "0        11DEOXY  [11 deoxycortisol, Cortodoxin, Deoxycorticoste...\n",
       "1          17OHP  [17 hydroxyprogesterone, 17-Hydroxyprogesteron...\n",
       "2          ACACT  [acetoacetate, AcAc, Acetoacetic Acid, Diaceti...\n",
       "3            ALT  [alanine transaminase, SGPT, Serum Glutamate P...\n",
       "4            ALB  [albumin, Serum Albumin, Human Albumin, Plasma...\n",
       "..           ...                                                ...\n",
       "254          PDW  [Platelet Distribution Width, Platelet Width, ...\n",
       "255        TFT-R  [Thyroid Function Test - Reflex, Thyroid Funct...\n",
       "256          TFT  [Thyroid Function Test, Thyroid Function Panel...\n",
       "257        TPOAb  [Thyroid Peroxidase Antibodies, Anti-Thyroid P...\n",
       "258         TgAb  [Thyroglobulin Antibodies, Anti-Thyroglobulin ...\n",
       "\n",
       "[259 rows x 2 columns]"
      ]
     },
     "execution_count": 30,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "abbr_list = pd.read_json('X1.json')\n",
    "abbr_list"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 31,
   "id": "189c48c0",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "['./OCR data/02b832e1-66cc-4f35-8b52-abf41cd821b2.txt',\n",
       " './OCR data/0ecb52fd-138f-4566-bdef-06fabdd7019d.txt',\n",
       " './OCR data/0b8706dc-c9af-4c6b-887d-2f85b5a511e7.txt',\n",
       " './OCR data/0ea75106-2a9d-4adc-9dad-33256e7d9aad.txt',\n",
       " './OCR data/0c848136-de54-49eb-a3c4-b04dda11ef42.txt',\n",
       " './OCR data/0ca602c0-d93a-4ae2-b91f-532db7e174ae.txt',\n",
       " './OCR data/0deee5f5-f9d3-4712-8d2e-c5f7cd9895dc.txt',\n",
       " './OCR data/0ab9800e-bc9a-4388-aaa2-d4fc05e7d111.txt',\n",
       " './OCR data/0c59298d-4205-4f6a-8bc9-c078123da03a.txt']"
      ]
     },
     "execution_count": 31,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "records = glob.glob('./OCR data/*.txt')\n",
    "records"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 32,
   "id": "0c93a8ba",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "------------------------------------- Start record --------------------------------\n",
      "Patient Name ee Barcode ; [eennnennninittte\n",
      "\n",
      " \n",
      "\n",
      "Age: Gender : 64/Female Sample Collected On : 03/Mar/2022 07:16AM\n",
      "Order Id : 483940780 Sample Received On : 03/Mar/2022 11:54AM\n",
      "Referred By : Self Report Generated On : 03/Mar/2022 12:57PM\n",
      "Customer Since : 03/Mar/2022 Sample Temperature : Maintained Y\n",
      "Sample Type : Whole Blood EDTA Report Status : Final Report\n",
      "DEPARTMENT OF BIOCHEMISTRY HBAIC\n",
      "Test Name Value Unit Bio. Ref Interval\n",
      "\n",
      "HbAlIc - Glycated Hemoglobin\n",
      "\n",
      "Hbalc (Glycosylated Hemoglobin) | 10.50 % 4.2-5.7\n",
      "Method: HPLC\n",
      "\n",
      "Average Estimated Glucose - plasma 254.65 mg/dt\n",
      "\n",
      "Method: Calculated\n",
      "\n",
      "INTERPRETATION:\n",
      "\n",
      "        \n",
      "  \n",
      "  \n",
      " \n",
      " \n",
      " \n",
      " \n",
      "  \n",
      "\n",
      "AS PER AMERICAN DIABETES ASSOCIATION (ADA): +\n",
      "\n",
      "REFERENCE GROUP GLYCOSYLATED HEMOGLOBIN (HBA‘Cc) in %\n",
      "Non diabetic <5.7\n",
      "At Risk (Prediabetes) 5.7 -6.4\n",
      "Diagnosing Diabetes >=6.5\n",
      "\n",
      "Age > 19 Years\n",
      "\n",
      "Goals of Therapy: <7.0\n",
      "Actions Suggested: >8.0\n",
      "Therapeutic goals for glycemic control Age < 19 Years\n",
      "\n",
      "| Goal of thera\n",
      "\n",
      "   \n",
      "\n",
      "REMARKS\n",
      "\n",
      "1. HbA1c is used for monitoring diabetic control. It reflects the mean plasma glucose over three months\n",
      "\n",
      "2. HbAic may be falsely low in diabetics with hemolytic disease. In these individuals a plasma fructosamine level may be used which evaluates diabetes over 15\n",
      "days.\n",
      "\n",
      "3. Inappropriately low HbA1c values may be reported due to hemolysis, recent blood transfusion, acute blood loss, hypertriglyceridemia, chronic liver disease.\n",
      "Drugs like dapsone, ribavinn, antiretroviral drugs, trimethoprim, may also cause interference with estimation of HbA1c, causing falsely low values.\n",
      "\n",
      "4. HbA1c may be increased in patients with polycythemia or post-splenectomy.\n",
      "\n",
      "5. Inappropriately higher values of HbA1c may be caused due to iron deficiency, vitamin B12 deficiency, alcohol intake, uremia, hyperbilirubinemia and large doses\n",
      "of aspirin. -\n",
      "\n",
      "6. Trends in HbA1c are a better indicator of diabetic control than a solitary test. 7. Any sample with >15% HbA1c should be suspected of having a hemoglobin\n",
      "vanant, especially in a non-diabetic patient. Similarly, below 4% should prompt additional studies to determine the possible presence of variant hemoglobin.\n",
      "\n",
      "8. HbA 1c target in pregnancy is to attain level <6 % .\n",
      "\n",
      "9. HbA‘1c target in paediatric age group is to attain level < 7.5 %.\n",
      "\n",
      "Method : lon-exchange high-performance liquid chromatography (HPLC).\n",
      "\n",
      "Reference : American Diabetes Associations. Standards of Medical Care in Diabetes 2015\n",
      "\f",
      "\n",
      "------------------------------------- End record ----------------------------------\n",
      "\n",
      "\n",
      "\n",
      "------------------------------------- Start record --------------------------------\n",
      "Peghy «Ao ¢4 AG +48 | 38 —> CLINICAL LABORATORIE Page HH1\n",
      "\n",
      "lj * I\n",
      ", mMnica LABORATORY 3427-3420 Referred: 02/02/24\n",
      "\n",
      "\n",
      "Clinical Notes: diabtetic urticaria\n",
      "\n",
      "HAEMATOLOGY SPECIMEN: WHOLE BLOOD\n",
      "Date: 05/02/24 07/12/22 10/06/21 (#Refers to current\n",
      "Coll. Time: 08:45 08:30 09:00 result only)\n",
      "Lab Number:\n",
      "\n",
      "HAEMOGLOEIN 138 133 126 (115 - 165) g/L\n",
      "RBC 5.02 4.77 4.48 (3.80 - 5.50)x10l4/L\n",
      "HCT QO.45 0.43 O.41 (0.35 - 0.47)\n",
      "\n",
      "MCV 90 91 91 (80 - 99) CL\n",
      "MCH 27.5 27.9 28.1 (27.0 - 34.0)pgq\n",
      "MCHC * 305 * 306 * 309 (310 - 360) g/L\n",
      "RDW 14.1 12.8 12.9 (11.0 - 15.0)%\n",
      "wee 6.8 7.4 6.5 (4.0 - 11.0} x107/L\n",
      "Neutrophils 2.4 3.8 2.7 (2.0 - 8.0) x“107/L\n",
      "Lymphocytea 3.6 3.0 3.0 (1.0 - 4.0) x107/L\n",
      "Monocytea 0.5 0.4 0.4 (< 1.1) x107/L\n",
      "Eosinophils 0.3 O.1 0.3 (« 0.7) x107/L\n",
      "Basophils < 0.1 0.0 < 0.1 (fe 0.3) *x107/L\n",
      "PLATELETS 308 336 200 (150 - 450) x107/L\n",
      "ESR 5 13 (< 21) mm /h\n",
      "#86820229 : Persistent red cell hypochromia. Serum ferritin is pending. I\n",
      "\n",
      "1ron atores are normal consider thalasdaemia screen. ESR is normal.\n",
      "\n",
      "CRP-R,GLS-R,GHB-R,OHD-R,RAS-W,B12-R, ESR-R,FBE-R,1I5-R,LIP-R, ECU-R, LET-+4++4+\n",
      "Page: 1 of 7\n",
      "REMOVED\n",
      "\f",
      "\n",
      "Peghy «Ao ¢4 AG +48 52 —> CLINICAL LABORATORIE Page HHZ\n",
      "\n",
      "lj * I\n",
      ", mMnica LABORATORY 3427-3420 Referred: 02/02/24\n",
      "\n",
      "\n",
      "Clinical Notes: diabtetic urticaria\n",
      "\n",
      "GENERAL CHEMISTEY SPECIMEN: SERUM\n",
      "\n",
      "Date: 05/02/24 07/12/22 10/06/21\n",
      "\n",
      "Coll. Time: QO8:45 08:30 09:00\n",
      "\n",
      "Lab Number:\n",
      "\n",
      "\n",
      "Sodium 139 139 138 (135 - 145} mmol /L\n",
      "Potassium 4.2 4.1 4.5 (3.5 - 5.2} mmol /L\n",
      "Chloride 101 104 105 (95 - 110) mmol /L\n",
      "Bicarbonate 27 25 24 (BB - 323} mmol /L\n",
      "Urea 6.0 5.8 4.2 (3.5 - 8.0} mmol /L\n",
      "Creatinine 54 52 45 (45 - 90} umol /L\n",
      "eGFR > 90 > 90 > 90 (> 59) mL/min/1.73m2\n",
      "T.Protein 65 67 68 (60 - 80} g/L\n",
      "Albumin 38 35 37 (35 - 50) g/L\n",
      "Globulin 27 32 31 (23 - 39) g/L\n",
      "ALP a7 B7 68 (30 - 110) U/L\n",
      "Bilirubin 9 7 7 (3 - 30) umol /L\n",
      "GGT 16 12 14 (5 - 35) U/L\n",
      "AST 13 15 * 41 (5 - 30) U/L\n",
      "ALT zal 17 15 (5 - 35) U/L\n",
      "\n",
      "86820229 Within reference intervals.\n",
      "\n",
      "Please note: from 09.11.23 new reference intervals apply for Liver\n",
      "Funetion Tests. These are sourced from the RCPA Harmonised\n",
      "Reference Intervals (v2.0) document.\n",
      "\n",
      "CRP-R,GLS-R,GHB-R,OHD-R,RAS-W,B12-R, ESR-R,FBE-R,1I5-R,LIP-R, ECU-R, LET-+4++4+\n",
      "Page: 2 of 7\n",
      "REMOVED\n",
      "\f",
      "\n",
      "Peghy «Ao G4 AG +49: 6 —> CLINICAL LABORATOURIE Page HHS\n",
      "\n",
      "lj * I\n",
      ", mMnica LABORATORY 3427-3420 Referred: 02/02/24\n",
      "\n",
      "\n",
      "Clinical Notes: diabtetic urticaria\n",
      "\n",
      "BIOCHEMISTRY\n",
      "C REACTIVE FPROTEIN (CRP) SPECIMEN: SHRUM\n",
      "REMOVED\n",
      "\n",
      "In the setting of infection, CRP levels +100 mg/L are supportive of\n",
      "bacterial rather than viral aetiology.\n",
      "\n",
      "Note resulta from this CRP aasay should not be used for cardiac risk\n",
      "agssedament. Please request the high sensitivity assay (hsCRP) inatead.\n",
      "\n",
      "BIOCHEMISTRY\n",
      "GLUCOSE\n",
      "Date Time Lab# Collection Type Specimen Glucose\n",
      "(mmol/L)\n",
      "95/02/24 08:45 618202xxx29 Fasting serum *# 1.7\n",
      "\n",
      "12351282555529 Elevated fasting glucose and HbAlc are consistent with\n",
      "diabetes.\n",
      "\n",
      "Suggest annual monitoring with urine albumin to detect diabetic\n",
      "nephropathy.\n",
      "\n",
      "Glucose Reference Ranges\n",
      "\n",
      "Random 3.0 - 6.9 mmol/L\n",
      "\n",
      "Fasting 3.0 - 5.4 mmol/L\n",
      "\n",
      "1 Hour post prandial 3.0 - 11.0 mmol/L\n",
      "\n",
      "2 Hour post prandial 3.0 - 7.7 mmol/L\n",
      "\n",
      "Specimen Legend:\n",
      "\n",
      "Fl-ox = Fluoride oxalate, serum = Serum, np = Non-Preserved\n",
      "\n",
      "CRP-R,GLS-R,GHB-R,OHD-R,RAS-W,B12-R, ESR-R,FBE-R,1I5-R,LIP-R, ECU-R, LET-+4++4+\n",
      "Page: 3 of 7\n",
      "REMOVED\n",
      "\f",
      "\n",
      "Feghy «Ao G4 yAG +4921 —> CLINICAL LABORATURIE Page HH4\n",
      "\n",
      "li * I\n",
      "Anica LABORATORY 3427-3420 Referred: 02/02/24\n",
      "\n",
      "Clinical Notes: diabtetic urticaria\n",
      "BLOCHEMISTRY\n",
      "HAEMOGLOBIN Alc SPECIMEN: WHOLE BLOOD\n",
      "ITFCC DCCT\n",
      "Date Coll Time Req. No. HbAle (mmol/mol) HbAlca (%}\n",
      "05/03/24 08:45 86820229 BR? KK 7.4\n",
      "07/12/22 08:30 72256123 BS KK 7.5\n",
      "\n",
      "BE6820229 RECOMMENDATIONS\n",
      "Consider review of diabetes management, if appropriate. Suggest repeat\n",
      "HbAle in 3 months. Note that urine microalbumin is now due.\n",
      "\n",
      "INTERPRETATION CRITERIA\n",
      "\n",
      "DIAGNOSIS.\n",
      "\n",
      "A HbAle greater than or equal to 48 mmol/mol ( 6.5 ¥%) 18 conalatent\n",
      "With diabetes. Consider OGTT or repeat HbAlec for confirmation.\n",
      "\n",
      "HbAlec 6.0 - 6.4% 18 consistent with prediabetes. Repeat testing annuall\n",
      "18 recommended. (ADS position atatement 2020)\n",
      "\n",
      "MONITORING.\n",
      "\n",
      "The Australian Diabetes Society (ADS) recommenda individualised HbAlc\n",
      "targeta depending on the patient's age, comorbidities and any\n",
      "Hypoglycaemia (ADS position statement 2009).\n",
      "\n",
      "A general target of less than or equal to 53 mmol/mol (7.0%) is often\n",
      "used.\n",
      "\n",
      "Please note that Hb Alec resulta may be influenced by conditiong\n",
      "affecting red cells or their survival times such as haemoglobinopathies\n",
      "anaemias, recent transfusion or blood loss.\n",
      "\n",
      "HbAle tested on Roche ¢513 using Gen. 3 assay.\n",
      "\n",
      "CRP-R,GLS-R,GHB-R,OHD-R,RAS-W,B12-R, ESR-R,FBE-R,1I5-R,LIP-R, ECU-R, LET-+4++4+\n",
      "Page: 4 of 7\n",
      "REMOVED\n",
      "\f",
      "\n",
      "Peghy «Ao G4 AG +49 «38 —> CLINICAL LABORATORIE Page HHS\n",
      "\n",
      "lj * I\n",
      ", mMnica LABORATORY 3427-3420 Referred: 02/02/24\n",
      "\n",
      "\n",
      "Clinical Notes: diabtetic urticaria\n",
      "\n",
      "BIOCHEMISTRY\n",
      "\n",
      "LIPID STUDIES SPECIMEN: SERUM\n",
      "Date: 05/02/24 07/12/22 10/06/21\n",
      "Coll. Time: 08:45 08:30 09:00 Desirable Range\n",
      "Lab Number:\n",
      "\n",
      "Faating Status Fasting Faating Fasting\n",
      "Total Chol. * 6.0 * 6.23 * 6.2 (« 5.6) mmol /\n",
      "HDL Chel. * 1.1 1.1 * 1.0 (> 1.1) mmol /\n",
      "LDL Chel. * 3.7 * 3.9 * 4,3 (x 3.1) mmol /\n",
      "Non-HDL Chel. * 4.9 * 5.1 * 5.2 (x 4.1) mmol /\n",
      "Triglyceride * 2.6 * 2.7 = * 2.0 (< 2.1) mmol /\n",
      "LDL/HDL Ratio 3.4 3.6 4.3\n",
      "Chol/HDL Ratio 5.4 5.6 6.2\n",
      "\n",
      "86820229 History of Diabetes. Interpret in conjunction with other\n",
      "cardiovascular risk factors or treatment targeta.\n",
      "\n",
      "Recommended targeta for high riak patients are\n",
      "\n",
      "Total cholesterol <« 4.0 mmol/L\n",
      "HDL Cholesterol > 1.0 mmol/L\n",
      "LDL Cholesterol =< 2.5 mmol/L ( < 1.8 mmol/L for very high risk)\n",
      "Non-HDL Cholesterol “= 3.3 mmol/L ( <« 2.5 mmol/L for very high risk)\n",
      "\n",
      "Fasting triglycerides < 2.0 mmol/L\n",
      "\n",
      "Lipid ranges and targets are from the AACB Guideline for Harmonised Lipi\n",
      "Reporting (2018)\n",
      "\n",
      "Target values need to be individualised based on clinical assesament of\n",
      "overall risk.\n",
      "\n",
      "See the AusCVD Risk calculator at www.cvdcheck.org.au\n",
      "\n",
      "CRP-R,GLS-R,GHB-R,OHD-R,RAS-W,B12-R, ESR-R,FBE-R,1I5-R,LIP-R, ECU-R, LET-+4++4+\n",
      "Page: 5 of 7\n",
      "REMOVED\n",
      "\f",
      "\n",
      "Peghy «Ao G4 AG +49 554 —> CLINICAL LABORATORIE Page HHo\n",
      "\n",
      "lj * I\n",
      ", mMnica LABORATORY 3427-3420 Referred: 02/02/24\n",
      "\n",
      "\n",
      "Clinical Notes: diabtetic urticaria\n",
      "\n",
      "BIOCHEMISTRY\n",
      "\n",
      "LRON STUDIES SPECIMEN: SHRUM\n",
      "Date: 05/02/24 10/06/21\n",
      "Coll. Time: O8:45 09:00\n",
      "Lab Number:\n",
      "\n",
      "\n",
      "Tron 14.6 * 8.7 (10.0 - 30.0) umol/\n",
      "Transferrin 2.64 2.56 (2.10 - 3.80) g/L\n",
      "Saturation 22 * 14 (15 - 45} %\n",
      "Ferritin * 26 * 28 (30 - 300) ug /L\n",
      "\n",
      "86820229 Iron studies are consistent with iron deficiency.\n",
      "\n",
      "BIOCHEMISTRY\n",
      "\n",
      "VITAMIN Bl2 AND FOLATE SPECIMEN: SERUM/BLOOD\n",
      "Date: 05/02/24 10/06/21\n",
      "\n",
      "Time: 08:45 09:00\n",
      "\n",
      "Lab Number:\n",
      "\n",
      "\n",
      "Vitamin B12 412 526 pmol/L\n",
      "Folate > 54.5 nmol/L\n",
      "\n",
      "86820229 Normal Bl2 result.\n",
      "\n",
      "RANGES Biz Serum Folate Red Cell Folate\n",
      "Normal > 180 > 10.90 > 450\n",
      "Equivocal 150 - 180 8.0 - 10.0 350 - 450\n",
      "Deficient « 150 -« 5.0 « 350\n",
      "\n",
      "Vitamin Bl2 and Folate analyses are performed on the Siemena Centaur/\n",
      "Atellica.\n",
      "\n",
      "CRP-R,GLS-R,GHB-R,OHD-R,RAS-W,B12-R, ESR-R,FBE-R,1I5-R,LIP-R, ECU-R, LET-+4++4+\n",
      "Page: 6 of 7\n",
      "REMOVED\n",
      "\f",
      "\n",
      "Peabo 64 AG: 58 + BB —> CLINICAL LABORATURIE Page HH?\n",
      "\n",
      "lj * I\n",
      ", mMnica LABORATORY 3427-3420 Referred: 02/02/24\n",
      "\n",
      "\n",
      "Clinical Notes: diabtetic urticaria\n",
      "\n",
      "ENDOCRINOLOGY\n",
      "THYROID FUNCTION TEST SPECIMEN: SERUM\n",
      "\n",
      "Date: 05/02/24 07/12/22 10/06/21\n",
      "\n",
      "Coll. Time: 08:45 08:30 09:00\n",
      "\n",
      "Lab Number:\n",
      "\n",
      "\n",
      "TSH 2.37 2.31 2.30 (0.40 - 4,.00)mIU/L\n",
      "\n",
      "868202295 Normal TSH level.\n",
      "\n",
      "BLOCHEMISTRY\n",
      "VITAMIN D SPECIMEN: SEHEREUM\n",
      "25-hydroxy\n",
      "REMOVED\n",
      "86820229 Within normal limita.\n",
      "\n",
      "Interpretation:\n",
      "Vitamin D deficiency <50 nmol/L\n",
      "Severe deficiency <20 nmol/L\n",
      "\n",
      "COMMENT: Vitamin D sufficiency is defined as greater than or equal to\n",
      "50 nmol/L at the end of winter (level may need to be 10-20 nmol/L highe\n",
      "at the end of gummer).\n",
      "\n",
      "Reference: Position Statement. Vitamin D and Health in Adults in\n",
      "Australia and New Zealand. MJA,196(11): 686-687, 2012.\n",
      "\n",
      "CRP-R,GLS-R,GHB-R,OHD-R,RAS-W,B12-R, ESR-R,FBE-R,1I5-R,LIP-R, ECU-R, LET-+4++4+\n",
      "Page: 7 of 7\n",
      "REMOVED\n",
      "\f",
      "\n",
      "------------------------------------- End record ----------------------------------\n",
      "\n",
      "\n",
      "\n",
      "------------------------------------- Start record --------------------------------\n",
      "Patient Health Summary\n",
      "\n",
      "removed\n",
      "\n",
      "removed\n",
      "\n",
      "\n",
      "D.O.B.: \n",
      "\n",
      "Record No.:\n",
      "\n",
      "Home Phone:\n",
      "\n",
      "Work Phone:\n",
      "\n",
      "removed\n",
      "\n",
      "Printed on 27th February 2024\n",
      "\n",
      " \n",
      "\n",
      "Investigations:\n",
      "\n",
      "removed\n",
      "\n",
      "removed\n",
      "\n",
      "removed\n",
      "\n",
      "remoed\n",
      "\n",
      "Laboratory: dhm\n",
      "\n",
      "removed\n",
      "\n",
      "Name of Test: MSU\n",
      "Requested: 30/01/2024 Collected: 30/01/2024 Reported: 13/02/2024 17:17\n",
      "\n",
      "Clinical notes: 2? UTI\n",
      "\n",
      "Clinical Notes : ? UTI\n",
      "\n",
      "Urine\n",
      "\n",
      "pH 7 Protein Nil Glucose Nil\n",
      "\n",
      "Blood Nil Ketones Nil\n",
      "\n",
      "Specific gravity 1.012 (1.005 - 1.030)\n",
      "\n",
      "Microscopy\n",
      "\n",
      "Leucocytes 5 x10*6/L ( <10 )\n",
      "Erythrocytes H 14 x10*6/L ( <10 )\n",
      "Epithelial cells 5 x10*6/L\n",
      "\n",
      "Growth of bowel/perineal flora\n",
      "Comment on Lab ID 887475034\n",
      "\n",
      "UTI is unlikely without a high white cell count in urine.\n",
      "\n",
      "NATA Accreditation No 2178\n",
      "\n",
      "Tests Completed: MSU\n",
      "Tests Pending\n",
      "Sample Pending\n",
      "\n",
      "removed\n",
      "\n",
      "removed\n",
      "\n",
      "removed\n",
      "\n",
      "remoed\n",
      "\n",
      "Laboratory: dhm\n",
      "\n",
      "removed\n",
      "\n",
      "Copy to:\n",
      "\n",
      "removed\n",
      "\f",
      "\n",
      "removed\n",
      "\n",
      "Name of Test: Rubella IgG, IgM\n",
      "\n",
      "Requested: 30/01/2024 Collected: 31/01/2024 Reported: 13/02/2024 17:17\n",
      "Clinical notes: pregnancy planning\n",
      "\n",
      "Clinical Notes : pregnancy planning\n",
      "\n",
      "Rubella Serology\n",
      "Rubella IgG (CMIA) 11 IU/mL\n",
      "\n",
      "Comment on Lab ID 838828312\n",
      "\n",
      "<5 IU/mL: Not immune\n",
      "5-9 IU/mL: Equivocal\n",
      ">/=10 IU/mL: Immune\n",
      "\n",
      "Antibody detected. In an asymptomatic individual this result is consistent\n",
      "with past infection or vaccination and correlates with protective\n",
      "immunity.\n",
      "\n",
      "NATA Accreditation No 2178\n",
      "\n",
      "Tests Completed: LFT(s),C(s),UCreat(s),E(s),Glu(s),Phos(s),Iron(s),\n",
      "Lipids HDL(s),Ca(s),Mg(s),Vit D(s),TSH(s),HBsAb(s),\n",
      "HB-Sero, FBC (e) ,RubG(s)\n",
      "\n",
      "Tests Pending\n",
      "\n",
      "Sample Pending\n",
      "\n",
      "removed\n",
      "\n",
      "removed\n",
      "\n",
      "removed\n",
      "\n",
      "remoed\n",
      "Your Reference: Lab Reference: removed\n",
      "\n",
      "Laboratory: dhm\n",
      "\n",
      "removed\n",
      "\n",
      "Copy to:\n",
      "\n",
      "removed\n",
      "\n",
      "Name of Test: Biochemistry\n",
      "\n",
      "Requested: 30/01/2024 Collected: 31/01/2024 Reported: 13/02/2024 17:17\n",
      "Clinical notes: pregnancy planning\n",
      "Clinical Notes : pregnancy planning\n",
      "\n",
      "BIOCHEMISTRY\n",
      "\n",
      "Date 29/01/19 28/07/23 14/08/23 31/01/24\n",
      "\n",
      "Time F-Fast 1640 0839 F 1248 0727 F\n",
      "\n",
      "Lab ID 295348768 885515368 887902883 838828312 Units Reference\n",
      "Status Fasting Fasting\n",
      "\n",
      "Sodium 140 L 134 139 140 mmol/L (135-145)\n",
      "Potassium 4.9 5.5 4.8 4.5 mmol/L (3.5-5.5)\n",
      "Chloride 106 106 107 106 mmol/L (95-110)\n",
      "Bicarbonate 23 21 21 25 mmol/L (20-32)\n",
      "Urea 4.0 4.8 5.3 5.1 mmol/L (2.5-7.0)\n",
      "Creatinine 70 70 65 65 umol/L (45-85)\n",
      "eGFR >90 >90 >90 >90 mL/min/1.73m2 (>59)\n",
      "Calcium 2.40 mmol/L (2.15-2.55)\n",
      "Corr Calcium 2.34 mmol/L (2.15-2.55)\n",
      "Magnesium. 0.84 mmol/L (0.65-1.00)\n",
      "Phosphate. 1.08 mmol/L (0.8-1.5)\n",
      "\n",
      "removed\n",
      "\f",
      "\n",
      "Bili.Total 11 H 20 H 18 umol/L (3-15)\n",
      "\n",
      "ALP 59 60 70 U/L (20-105)\n",
      "GGT 13 11 15 U/L (5-35)\n",
      "\n",
      "LD 187 203 178 U/L (120-250)\n",
      "AST 19 25 23 U/L (10-35)\n",
      "ALT 16 12 22 U/L (5-30)\n",
      "Total Protein 76 70 72 g/L (68-85)\n",
      "Albumin 46 44 46 g/L (37-48)\n",
      "Globulin 30 26 26 g/L (23-39)\n",
      "Cholesterol 4.7 mmol/L (<5.5)\n",
      "Triglycerides 0.6 mmol/L (<2.0)\n",
      "\n",
      "Comments on Collection 31/01/24 0727 F:\n",
      "eGFR (mL/min/1.73m2) calculated by CKD-EPI formula - see www.kidney.org.au\n",
      "\n",
      "NATA Accreditation No 2178\n",
      "\n",
      "Tests Completed: LFT(s),C(s),UCreat(s),E(s),Glu(s),Phos(s),Iron(s),\n",
      "Lipids HDL(s),Ca(s),Mg(s),Vit D(s),TSH(s),HBsAb(s),\n",
      "HB-Sero, FBC (e) ,RubG(s)\n",
      "\n",
      "Tests Pending\n",
      "\n",
      "Sample Pending\n",
      "\n",
      "removed\n",
      "\n",
      "removed\n",
      "\n",
      "removed\n",
      "\n",
      "remoed\n",
      "Your Reference: Lab Reference: removed\n",
      "\n",
      "Laboratory: dhm\n",
      "\n",
      "removed\n",
      "\n",
      "Copy to:\n",
      "\n",
      "removed\n",
      "\n",
      "Name of Test: _ Glucose\n",
      "\n",
      "Requested: 30/01/2024 Collected: 31/01/2024 Reported: 13/02/2024 17:17\n",
      "Clinical notes: pregnancy planning\n",
      "Clinical Notes : pregnancy planning\n",
      "\n",
      "GLUCOSE\n",
      "\n",
      "Date 23/12/17 24/09/18 28/07/23 31/01/24\n",
      "\n",
      "Time F-Fast 0825 F 1100 0839 F 0727 F\n",
      "\n",
      "Lab ID 266516640 282139635 885515368 838828312 Units Reference\n",
      "F Gluc Plasma 4.5 4.7 mmol/L (3.6-6.0)\n",
      "R Gluc Plasma 4.5 mmol/L (3.6-7.8)\n",
      "F Gluc Serum 4.8 mmol/L (3.6-6.0)\n",
      "\n",
      "Comments on Collection 31/01/24 0727 F:\n",
      "\n",
      "Diabetes is unlikely if fasting glucose levels are less than 5.5 mmol/L but\n",
      "an OGTT could be indicated in the presence of risk factors such as\n",
      "metabolic syndrome, past gestational diabetes, polycystic ovary or family\n",
      "history of type 2 diabetes.\n",
      "\n",
      "NATA Accreditation No 2178\n",
      "\n",
      "Tests Completed: LFT(s),C(s),UCreat(s),E(s),Glu(s),Phos(s),Iron(s),\n",
      "Lipids HDL(s),Ca(s),Mg(s),Vit D(s),TSH(s),HBsAb(s),\n",
      "HB-Sero, FBC (e) ,RubG(s)\n",
      "\n",
      "Tests Pending\n",
      "\n",
      "Sample Pending\n",
      "\n",
      "removed\n",
      "removed\n",
      "\n",
      "removed\n",
      "\f",
      "\n",
      "removed\n",
      "\n",
      "remoed\n",
      "Your Reference: Lab Reference: removed\n",
      "\n",
      "Laboratory: dhm\n",
      "\n",
      "removed\n",
      "\n",
      "Copy to:\n",
      "\n",
      "removed\n",
      "\n",
      "Name of Test: Iron Studies\n",
      "\n",
      "Requested: 30/01/2024 Collected: 31/01/2024 Reported: 13/02/2024 17:17\n",
      "Clinical notes: pregnancy planning\n",
      "Clinical Notes : pregnancy planning\n",
      "\n",
      "IRON\n",
      "\n",
      "Date 23/12/17 29/01/19 28/07/23 31/01/24\n",
      "\n",
      "Time F-Fast 0825 F 1640 0839 F 0727 F\n",
      "\n",
      "Lab ID 266516640 295348768 885515368 838828312 Units Reference\n",
      "Tron 11.5 12.2 24.9 umol/L (5.0-30.0)\n",
      "Transferrin 2.2 2.5 2.7 g/L (2.0-3.6)\n",
      "TIBC (Calc) 50 56 60 umol/L (46-77)\n",
      "Saturation 23 22 42 % (10-45)\n",
      "Ferritin 38 719 39 47 ug/L (15-200)\n",
      "\n",
      "NATA Accreditation No 2178\n",
      "\n",
      "Tests Completed: LFT(s),C(s),UCreat(s),E(s),Glu(s),Phos(s),Iron(s),\n",
      "Lipids HDL(s),Ca(s),Mg(s),Vit D(s),TSH(s),HBsAb(s),\n",
      "HB-Sero, FBC (e) ,RubG(s)\n",
      "\n",
      "Tests Pending\n",
      "\n",
      "Sample Pending\n",
      "\n",
      "removed\n",
      "\n",
      "removed\n",
      "\n",
      "removed\n",
      "\n",
      "remoed\n",
      "Your Reference: Lab Reference: removed\n",
      "\n",
      "Laboratory: dhm\n",
      "\n",
      "removed\n",
      "\n",
      "Copy to:\n",
      "\n",
      "removed\n",
      "\n",
      "Name of Test: Lipids HDL(s)\n",
      "\n",
      "Requested: 30/01/2024 Collected: 31/01/2024 Reported: 13/02/2024 17:17\n",
      "Clinical notes: pregnancy planning\n",
      "Clinical Notes : pregnancy planning\n",
      "\n",
      "Date 23/12/17 31/01/24\n",
      "\n",
      "Time F-Fast 0825 F 0727 F\n",
      "\n",
      "Lab ID 266516640 838828312 Units Reference\n",
      "Status Fasting Fasting\n",
      "\n",
      "Cholesterol L 3.8 4.7 mmol/L (<5.5)\n",
      "Triglycerides 0.5 0.6 mmol/L (<2.0)\n",
      "HDL Chol. 1.6 2.0 mmol/L (>1.2)\n",
      "LDL Chol. 2.0 2.4 mmol/L (<3.0)\n",
      "Non-HDL Chol. a | mmol/L (<4.0)\n",
      "\n",
      "Comments on Collection 31/01/24 0727 F:\n",
      "\n",
      "Please note that the above reference limits are decision limits.\n",
      "\n",
      "A flag based on these limits is an indication to review the absolute\n",
      "cardiovascular risk for the patient. For assessment of absolute\n",
      "cardiovascular disease risk please see www.cvdcheck.org.au\n",
      "\n",
      "removed\n",
      "\f",
      "\n",
      "The above decision limits are based on the European Atherosclerosis Society\n",
      "(EAS) and European Federation of Clinical Chemistry and Laboratory Medicine\n",
      "(EFLM) Consensus Statement 2016 and the Australasian Association of\n",
      "Clinical Biochemistry and Laboratory Medicine (AACB) Lipid Reporting\n",
      "Guideline 2018.\n",
      "\n",
      "Lipid treatment targets for patients at high risk of cardiovascular\n",
      "disease:\n",
      "\n",
      "Total cholesterol <4.0 mmol/L\n",
      "\n",
      "Triglyceride <2.0 mmol/L\n",
      "\n",
      "HDL cholesterol >1.0 mmol/L\n",
      "\n",
      "LDL cholesterol <2.5 mmol/L (<1.8 mmol/L for very high risk)\n",
      "Non-HDL cholesterol <3.3 mmol/L (<2.5 mmol/L for very high risk)\n",
      "High risk - Primary prevention Very high risk - Secondary prevention\n",
      "\n",
      "Target values from the AACB Lipid Reporting Guideline 2018.\n",
      "\n",
      "Please note that as there is a continuum of risk, benefits are obtained for\n",
      "any measured lipid components moving towards and beyond the various target\n",
      "levels.\n",
      "\n",
      "NATA Accreditation No 2178\n",
      "\n",
      "Tests Completed: LFT(s),C(s),UCreat(s),E(s),Glu(s),Phos(s),Iron(s),\n",
      "Lipids HDL(s),Ca(s),Mg(s),Vit D(s),TSH(s),HBsAb(s),\n",
      "HB-Sero, FBC (e) ,RubG(s)\n",
      "\n",
      "Tests Pending\n",
      "\n",
      "Sample Pending\n",
      "\n",
      "removed\n",
      "\n",
      "removed\n",
      "\n",
      "removed\n",
      "\n",
      "remoed\n",
      "Your Reference: Lab Reference: removed\n",
      "\n",
      "Laboratory: dhm\n",
      "\n",
      "removed\n",
      "\n",
      "Copy to:\n",
      "\n",
      "removed\n",
      "\n",
      "Name of Test: Haematology\n",
      "\n",
      "Requested: 30/01/2024 Collected: 31/01/2024 Reported: 13/02/2024 17:17\n",
      "Clinical notes: pregnancy planning\n",
      "Clinical Notes : pregnancy planning\n",
      "\n",
      "HAEMATOLOGY\n",
      "\n",
      "Date 24/09/18 29/01/19 28/07/23 31/01/24\n",
      "\n",
      "Time F-Fast 1100 1640 0839 F 0727 F\n",
      "\n",
      "Lab ID 282139635 295348768 885515368 838828312 Units Reference\n",
      "Haemoglobin 124 128 127 134 g/L (119-160)\n",
      "RCC 4.2 4.3 4.2 4.5 x10*12/L (3.8-5.8)\n",
      "Haematocrit 0.38 0.38 0.37 0.41 (0.35-0.48)\n",
      "MCV 90 88 87 92 £L (80-100)\n",
      "MCH 29.6 29.8 30.0 29.9 pg (27.0-32.0)\n",
      "MCHC 328 338 344 325 g/L (310-360)\n",
      "RDW 11.9 11.9 12.4 13.0 (10.0-15.0)\n",
      "wcc 7.7 8.4 9.3 7.9 x10*9/L (4.0-11.0)\n",
      "Neutrophils 4.32 4.50 4.69 4.11 x10*9/L (2.0-7.5)\n",
      "Lymphocytes 2.77 2.96 3.67 2.96 x10*9/L (1.0-4.0)\n",
      "Monocytes 0.52 0.76 0.63 0.59 x10*9/L (0.0-1.0)\n",
      "Eosinophils 0.07 0.11 0.22 0.17 x10*9/L (0.0-0.5)\n",
      "Basophils 0.04 0.07 0.04 0.04 x10*9/L (0.0-0.3)\n",
      "NRBC <1.0 <1.0 <1.0 <1.0 /100 WBC (<1)\n",
      "\n",
      "removed\n",
      "\f",
      "\n",
      "Platelets 221 267 234 261 x10*9/L (150-450)\n",
      "ESR 1 mm/h (1-22)\n",
      "\n",
      "Comments on Collection 31/01/24 0727 F:\n",
      "Full blood count is within reference limits\n",
      "\n",
      "NATA Accreditation No 2178\n",
      "\n",
      "Tests Completed: LFT(s),C(s),UCreat(s),E(s),Glu(s),Phos(s),Iron(s),\n",
      "Lipids HDL(s),Ca(s),Mg(s),Vit D(s),TSH(s),HBsAb(s),\n",
      "HB-Sero, FBC (e) ,RubG(s)\n",
      "\n",
      "Tests Pending\n",
      "\n",
      "Sample Pending\n",
      "\n",
      "removed\n",
      "\n",
      "removed\n",
      "\n",
      "removed\n",
      "\n",
      "remoed\n",
      "\n",
      "Laboratory: dhm\n",
      "\n",
      "removed\n",
      "\n",
      "Copy to:\n",
      "\n",
      "removed\n",
      "\n",
      "Name of Test: Hep B Serology\n",
      "\n",
      "Requested: 30/01/2024 Collected: 31/01/2024 Reported: 13/02/2024 17:17\n",
      "Clinical notes: pregnancy planning\n",
      "Clinical Notes : pregnancy planning\n",
      "\n",
      "Hepatitis B Serology\n",
      "Hepatitis B Surface Ab 31 IU/L\n",
      "Comment on Lab ID 838828312\n",
      "\n",
      "Hepatitis B - Immune (>/=10 IU/L).\n",
      "\n",
      "NATA Accreditation No 2178\n",
      "\n",
      "Tests Completed: LFT(s),C(s),UCreat(s),E(s),Glu(s),Phos(s),Iron(s),\n",
      "Lipids HDL(s),Ca(s),Mg(s),Vit D(s),TSH(s),HBsAb(s),\n",
      "HB-Sero, FBC (e) ,RubG(s)\n",
      "\n",
      "Tests Pending\n",
      "\n",
      "Sample Pending\n",
      "\n",
      "removed\n",
      "\n",
      "removed\n",
      "\n",
      "removed\n",
      "\n",
      "remoed\n",
      "\n",
      "Laboratory: dhm\n",
      "\n",
      "removed\n",
      "\n",
      "Copy to:\n",
      "\n",
      "removed\n",
      "\n",
      "Name of Test: Thyroid Function\n",
      "\n",
      "Requested: 30/01/2024 Collected: 31/01/2024 Reported: 13/02/2024 17:17\n",
      "Clinical notes: pregnancy planning\n",
      "Clinical Notes : pregnancy planning\n",
      "\n",
      "TET\n",
      "\n",
      "removed\n",
      "\f",
      "\n",
      "Date 23/12/17 24/09/18 14/08/23 31/01/24\n",
      "\n",
      "Time F-Fast 0825 F 1100 1248 0727 F\n",
      "Lab ID 266516640 282139635 887902883 838828312 Units Reference\n",
      "TSH 1.14 1.18 1.57 2.99 milU/L (0.40-3.50)\n",
      "\n",
      "NATA Accreditation No 2178\n",
      "\n",
      "Tests Completed: LFT(s),C(s),UCreat(s),E(s),Glu(s),Phos(s),Iron(s),\n",
      "Lipids HDL(s),Ca(s),Mg(s),Vit D(s),TSH(s),HBsAb(s),\n",
      "HB-Sero, FBC (e) ,RubG(s)\n",
      "\n",
      "Tests Pending\n",
      "\n",
      "Sample Pending\n",
      "\n",
      "removed\n",
      "\n",
      "removed\n",
      "\n",
      "removed\n",
      "\n",
      "remoed\n",
      "Your Reference: Lab Reference: removed\n",
      "\n",
      "Laboratory: dhm\n",
      "\n",
      "removed\n",
      "\n",
      "Copy to:\n",
      "\n",
      "removed\n",
      "\n",
      "Name of Test: Vit D(s)\n",
      "\n",
      "Requested: 30/01/2024 Collected: 31/01/2024 Reported: 13/02/2024 17:17\n",
      "Clinical notes: pregnancy planning\n",
      "Clinical Notes : pregnancy planning\n",
      "\n",
      "Date 28/07/23 31/01/24\n",
      "\n",
      "Time F-Fast 0839 F 0727 F\n",
      "\n",
      "Lab ID 885515368 838828312 Units Reference\n",
      "Vitamin D 73 83 nmol/L (50-140)\n",
      "\n",
      "Comments on Collection 31/01/24 0727 F:\n",
      "\n",
      "According to the Position Statement 'Vitamin D and health in adults in\n",
      "Australia and New Zealand' MJA, 196(11):686-687, 2012, Vitamin D status is\n",
      "defined as:\n",
      "\n",
      "Mild Deficiency 30 - 49 nmol/L\n",
      "Moderate Deficiency 12.5 - 29 nmol/L\n",
      "Severe Deficiency <12.5 nmol/L\n",
      "\n",
      "Vitamin D adequacy can be defined as a level >49 nmol/L at the end of\n",
      "winter - the level may need to be 10 - 20 nmol/L higher at the end of\n",
      "summer, to allow for seasonal decrease.\n",
      "\n",
      "From lst November 2014, Medicare rebates for vitamin D testing will apply\n",
      "to patients at risk of Vitamin D deficiency such as chronic lack of sun\n",
      "exposure.\n",
      "\n",
      "NATA Accreditation No 2178\n",
      "\n",
      "Tests Completed: LFT(s),C(s),UCreat(s),E(s),Glu(s),Phos(s),Iron(s),\n",
      "Lipids HDL(s),Ca(s),Mg(s),Vit D(s),TSH(s),HBsAb(s),\n",
      "HB-Sero, FBC (e) ,RubG(s)\n",
      "\n",
      "Tests Pending\n",
      "\n",
      "Sample Pending\n",
      "\n",
      "removed\n",
      "\n",
      "removed\n",
      "\n",
      "removed\n",
      "\n",
      "remoed\n",
      "\n",
      "removed\n",
      "\f",
      "\n",
      "Laboratory: dhm\n",
      "\n",
      "removed\n",
      "Copy to:\n",
      "removed\n",
      "\n",
      "Name of Test: Haematology\n",
      "\n",
      "Requested: 30/01/2024 Collected: 31/01/2024 Reported: 31/01/2024 11:47\n",
      "Clinical notes: pregnancy planning\n",
      "Clinical Notes : pregnancy planning\n",
      "\n",
      "HAEMATOLOGY\n",
      "\n",
      "Date 24/09/18 29/01/19 28/07/23 31/01/24\n",
      "\n",
      "Time F-Fast 1100 1640 0839 F 0727 F\n",
      "\n",
      "Lab ID 282139635 295348768 885515368 838828312 Units Reference\n",
      "Haemoglobin 124 128 127 134 g/L (119-160)\n",
      "RCC 4.2 4.3 4.2 4.5 x10*12/L (3.8-5.8)\n",
      "Haematocrit 0.38 0.38 0.37 0.41 (0.35-0.48)\n",
      "MCV 90 88 87 92 fL (80-100)\n",
      "MCH 29.6 29.8 30.0 29.9 pg (27.0-32.0)\n",
      "MCHC 328 338 344 325 g/L (310-360)\n",
      "RDW 11.9 11.9 12.4 13.0 (10.0-15.0)\n",
      "WCC 7.7 8.4 9.3 7.9 x10*9/L (4.0-11.0)\n",
      "Neutrophils 4.32 4.50 4.69 4.11 x10*9/L (2.0-7.5)\n",
      "Lymphocytes 2.77 2.96 3.67 2.96 x10*9/L (1.0-4.0)\n",
      "Monocytes 0.52 0.76 0.63 0.59 x10*9/L (0.0-1.0)\n",
      "Eosinophils 0.07 0.11 0.22 0.17 x10*9/L (0.0-0.5)\n",
      "Basophils 0.04 0.07 0.04 0.04 x10*9/L (0.0-0.3)\n",
      "NRBC <1.0 <1.0 <1.0 <1.0 /100 WBC (<1)\n",
      "Platelets 221 267 234 261 x10*9/L (150-450)\n",
      "ESR 1 mm/h (1-22)\n",
      "\n",
      "Comments on Collection 31/01/24 0727 F:\n",
      "Full blood count is within reference limits\n",
      "\n",
      "NATA Accreditation No 2178\n",
      "\n",
      "Tests Completed: FBC (e)\n",
      "\n",
      "Tests Pending : LFT(s),C(s),UCreat(s),E(s),Glu(s),Phos(s),Iron(s),\n",
      "Lipids HDL(s),Ca(s),Mg(s),Vit D(s),TSH(s),HBsAb(s),\n",
      "HB-Sero, RubG(s)\n",
      "\n",
      "Sample Pending\n",
      "\n",
      "removed\n",
      "\n",
      "removed\n",
      "\n",
      "removed\n",
      "\n",
      "remoed\n",
      "Your Reference: Lab Reference: removed\n",
      "\n",
      "Laboratory: dhm\n",
      "\n",
      "removed\n",
      "\n",
      "Copy to:\n",
      "\n",
      "removed\n",
      "\n",
      "Name of Test: Biochemistry\n",
      "\n",
      "Requested: 30/01/2024 Collected: 31/01/2024 Reported: 31/01/2024 12:17\n",
      "Clinical notes: pregnancy planning\n",
      "Clinical Notes : pregnancy planning\n",
      "\n",
      "BIOCHEMISTRY\n",
      "\n",
      "Date 29/01/19 28/07/23 14/08/23 31/01/24\n",
      "\n",
      "Time F-Fast 1640 0839 F 1248 0727 F\n",
      "\n",
      "Lab ID 295348768 885515368 887902883 838828312 Units Reference\n",
      "\n",
      "removed\n",
      "\f",
      "\n",
      "Status Fasting Fasting\n",
      "\n",
      "Sodium 140 L 134 139 140 mmol/L (135-145)\n",
      "Potassium 4.9 5.5 4.8 4.5 mmol/L (3.5-5.5)\n",
      "Chloride 106 106 107 106 mmol/L (95-110)\n",
      "Bicarbonate 23 21 21 25 mmol/L (20-32)\n",
      "Urea 4.0 4.8 5.3 5.1 mmol/L (2.5-7.0)\n",
      "Creatinine 70 70 65 65 umol/L (45-85)\n",
      "eGFR >90 >90 >90 >90 mL/min/1.73m2 (>59)\n",
      "Calcium 2.40 mmol/L (2.15-2.55)\n",
      "Corr Calcium 2.34 mmol/L (2.15-2.55)\n",
      "Magnesium. 0.84 mmol/L (0.65-1.00)\n",
      "Phosphate. 1.08 mmol/L (0.8-1.5)\n",
      "Bili.Total 11 H 20 H 18 umol/L (3-15)\n",
      "\n",
      "ALP 59 60 70 U/L (20-105)\n",
      "GGT 13 11 15 U/L (5-35)\n",
      "\n",
      "LD 187 203 178 U/L (120-250)\n",
      "AST 19 25 23 U/L (10-35)\n",
      "\n",
      "ALT 16 12 22 U/L (5-30)\n",
      "Total Protein 76 70 72 g/L (68-85)\n",
      "Albumin 46 44 46 g/L (37-48)\n",
      "Globulin 30 26 26 g/L (23-39)\n",
      "Cholesterol 4.7 mmol/L (<5.5)\n",
      "Triglycerides 0.6 mmol/L (<2.0)\n",
      "\n",
      "Comments on Collection 31/01/24 0727 F:\n",
      "eGFR (mL/min/1.73m2) calculated by CKD-EPI formula - see www.kidney.org.au\n",
      "\n",
      "NATA Accreditation No 2178\n",
      "\n",
      "Tests Completed: LFT(s),C(s),UCreat(s),E(s),Glu(s),Phos(s),\n",
      "Lipids HDL(s),Ca(s),Mg(s),FBC(e)\n",
      "\n",
      "Tests Pending : Iron(s),Vit D(s),TSH(s),HBSAb(s),HB-Sero, RubG(s)\n",
      "\n",
      "Sample Pending\n",
      "\n",
      "removed\n",
      "\n",
      "removed\n",
      "\n",
      "removed\n",
      "\n",
      "remoed\n",
      "Your Reference: Lab Reference: removed\n",
      "\n",
      "Laboratory: dhm\n",
      "\n",
      "removed\n",
      "\n",
      "Copy to:\n",
      "\n",
      "removed\n",
      "\n",
      "Name of Test: _Glucose\n",
      "\n",
      "Requested: 30/01/2024 Collected: 31/01/2024 Reported: 31/01/2024 12:17\n",
      "Clinical notes: pregnancy planning\n",
      "Clinical Notes : pregnancy planning\n",
      "\n",
      "GLUCOSE\n",
      "\n",
      "Date 23/12/17 24/09/18 28/07/23 31/01/24\n",
      "\n",
      "Time F-Fast 0825 F 1100 0839 F 0727 F\n",
      "\n",
      "Lab ID 266516640 282139635 885515368 838828312 Units Reference\n",
      "F Gluc Plasma 4.5 4.7 mmol/L (3.6-6.0)\n",
      "R Gluc Plasma 4.5 mmol/L (3.6-7.8)\n",
      "F Gluc Serum 4.8 mmol/L (3.6-6.0)\n",
      "\n",
      "Comments on Collection 31/01/24 0727 F:\n",
      "\n",
      "Diabetes is unlikely if fasting glucose levels are less than 5.5 mmol/L but\n",
      "an OGTT could be indicated in the presence of risk factors such as\n",
      "metabolic syndrome, past gestational diabetes, polycystic ovary or family\n",
      "history of type 2 diabetes.\n",
      "\n",
      "NATA Accreditation No 2178\n",
      "\n",
      "removed\n",
      "\f",
      "\n",
      "Tests Completed: LFT(s),C(s),UCreat(s),E(s),Glu(s),Phos(s),\n",
      "Lipids HDL(s),Ca(s),Mg(s),FBC(e)\n",
      "\n",
      "Tests Pending : Iron(s),Vit D(s),TSH(s),HBSAb(s),HB-Sero, RubG(s)\n",
      "\n",
      "Sample Pending\n",
      "\n",
      "removed\n",
      "\n",
      "removed\n",
      "\n",
      "removed\n",
      "\n",
      "remoed\n",
      "Your Reference: Lab Reference: removed\n",
      "\n",
      "Laboratory: dhm\n",
      "\n",
      "removed\n",
      "\n",
      "Copy to:\n",
      "\n",
      "removed\n",
      "\n",
      "Name of Test: Lipids HDL(s)\n",
      "\n",
      "Requested: 30/01/2024 Collected: 31/01/2024 Reported: 31/01/2024 12:17\n",
      "Clinical notes: pregnancy planning\n",
      "Clinical Notes : pregnancy planning\n",
      "\n",
      "Date 23/12/17 31/01/24\n",
      "\n",
      "Time F-Fast 0825 F 0727 F\n",
      "\n",
      "Lab ID 266516640 838828312 Units Reference\n",
      "Status Fasting Fasting\n",
      "\n",
      "Cholesterol L 3.8 4.7 mmol/L (<5.5)\n",
      "Triglycerides 0.5 0.6 mmol/L (<2.0)\n",
      "HDL Chol. 1.6 2.0 mmol/L (>1.2)\n",
      "LDL Chol. 2.0 2.4 mmol/L (<3.0)\n",
      "Non-HDL Chol. 2.7 mmol/L (<4.0)\n",
      "\n",
      "Comments on Collection 31/01/24 0727 F:\n",
      "\n",
      "Please note that the above reference limits are decision limits.\n",
      "\n",
      "A flag based on these limits is an indication to review the absolute\n",
      "cardiovascular risk for the patient. For assessment of absolute\n",
      "cardiovascular disease risk please see www.cvdcheck.org.au\n",
      "\n",
      "The above decision limits are based on the European Atherosclerosis Society\n",
      "(EAS) and European Federation of Clinical Chemistry and Laboratory Medicine\n",
      "(EFLM) Consensus Statement 2016 and the Australasian Association of\n",
      "Clinical Biochemistry and Laboratory Medicine (AACB) Lipid Reporting\n",
      "Guideline 2018.\n",
      "\n",
      "Lipid treatment targets for patients at high risk of cardiovascular\n",
      "disease:\n",
      "\n",
      "Total cholesterol <4.0 mmol/L\n",
      "\n",
      "Triglyceride <2.0 mmol/L\n",
      "\n",
      "HDL cholesterol >1.0 mmol/L\n",
      "\n",
      "LDL cholesterol <2.5 mmol/L (<1.8 mmol/L for very high risk)\n",
      "Non-HDL cholesterol <3.3 mmol/L (<2.5 mmol/L for very high risk)\n",
      "High risk - Primary prevention Very high risk - Secondary prevention\n",
      "\n",
      "Target values from the AACB Lipid Reporting Guideline 2018.\n",
      "\n",
      "Please note that as there is a continuum of risk, benefits are obtained for\n",
      "any measured lipid components moving towards and beyond the various target\n",
      "levels.\n",
      "\n",
      "NATA Accreditation No 2178\n",
      "\n",
      "Tests Completed: LFT(s),C(s),UCreat(s),E(s),Glu(s),Phos(s),\n",
      "Lipids HDL(s),Ca(s),Mg(s),FBC(e)\n",
      "\n",
      "Tests Pending : Iron(s),Vit D(s),TSH(s),HBSAb(s),HB-Sero, RubG(s)\n",
      "\n",
      "Sample Pending\n",
      "\n",
      "removed\n",
      "\f",
      "\n",
      "removed\n",
      "removed\n",
      "removed\n",
      "remoed\n",
      "Laboratory: dhm\n",
      "removed\n",
      "Copy to:\n",
      "removed\n",
      "\n",
      "Name of Test: Hep B Serology\n",
      "Requested: 30/01/2024 Collected: 31/01/2024 Reported: 01/02/2024 02:47\n",
      "\n",
      "Clinical notes: pregnancy planning\n",
      "\n",
      "Clinical Notes : pregnancy planning\n",
      "\n",
      "Hepatitis B Serology\n",
      "\n",
      "Hepatitis B Surface Ab 31 IU/L\n",
      "Comment on Lab ID 838828312\n",
      "\n",
      "Hepatitis B - Immune (>/=10 IU/L).\n",
      "\n",
      "NATA Accreditation No 2178\n",
      "\n",
      "Tests Completed: LFT(s),C(s),UCreat(s),E(s),Glu(s),Phos(s),Iron(s),\n",
      "Lipids HDL(s),Ca(s),Mg(s),TSH(s),HBsAb(s),HB-Sero,\n",
      "FBC (e) , RubG (s)\n",
      "\n",
      "Tests Pending : Vit D(s)\n",
      "\n",
      "Sample Pending\n",
      "\n",
      "removed\n",
      "\n",
      "removed\n",
      "\n",
      "removed\n",
      "\n",
      "remoed\n",
      "\n",
      "Laboratory: dhm\n",
      "\n",
      "removed\n",
      "\n",
      "Copy to:\n",
      "\n",
      "removed\n",
      "\n",
      "Name of Test: Rubella IgG, IgM\n",
      "\n",
      "Requested: 30/01/2024 Collected: 31/01/2024 Reported: 01/02/2024 02:47\n",
      "Clinical notes: pregnancy planning\n",
      "Clinical Notes : pregnancy planning\n",
      "\n",
      "Rubella Serology\n",
      "Rubella IgG (CMIA) 11 IU/mL\n",
      "\n",
      "Comment on Lab ID 838828312\n",
      "\n",
      "<5 IU/mL: Not immune\n",
      "5-9 IU/mL: Equivocal\n",
      ">/=10 IU/mL: Immune\n",
      "\n",
      "Antibody detected. In an asymptomatic individual this result is consistent\n",
      "with past infection or vaccination and correlates with protective\n",
      "immunity.\n",
      "\n",
      "removed\n",
      "\f",
      "\n",
      "NATA Accreditation No 2178\n",
      "\n",
      "Tests Completed: LFT(s),C(s),UCreat(s),E(s),Glu(s),Phos(s),Iron(s),\n",
      "Lipids HDL(s),Ca(s),Mg(s),TSH(s),HBsAb(s),HB-Sero,\n",
      "FBC (e) , RubG (s)\n",
      "\n",
      "Tests Pending : Vit D(s)\n",
      "\n",
      "Sample Pending\n",
      "\n",
      "removed\n",
      "\n",
      "removed\n",
      "\n",
      "removed\n",
      "\n",
      "remoed\n",
      "Your Reference: Lab Reference: removed\n",
      "\n",
      "Laboratory: dhm\n",
      "\n",
      "removed\n",
      "\n",
      "Copy to:\n",
      "\n",
      "removed\n",
      "\n",
      "Name of Test: Vit D(s)\n",
      "\n",
      "Requested: 30/01/2024 Collected: 31/01/2024 Reported: 01/02/2024 05:17\n",
      "Clinical notes: pregnancy planning\n",
      "Clinical Notes : pregnancy planning\n",
      "\n",
      "Date 28/07/23 31/01/24\n",
      "\n",
      "Time F-Fast 0839 F 0727 F\n",
      "\n",
      "Lab ID 885515368 838828312 Units Reference\n",
      "Vitamin D 73 83 nmol/L (50-140)\n",
      "\n",
      "Comments on Collection 31/01/24 0727 F:\n",
      "\n",
      "According to the Position Statement 'Vitamin D and health in adults in\n",
      "Australia and New Zealand' MJA, 196(11):686-687, 2012, Vitamin D status is\n",
      "defined as:\n",
      "\n",
      "Mild Deficiency 30 - 49 nmol/L\n",
      "Moderate Deficiency 12.5 - 29 nmol/L\n",
      "Severe Deficiency <12.5 nmol/L\n",
      "\n",
      "Vitamin D adequacy can be defined as a level >49 nmol/L at the end of\n",
      "winter - the level may need to be 10 - 20 nmol/L higher at the end of\n",
      "summer, to allow for seasonal decrease.\n",
      "\n",
      "From lst November 2014, Medicare rebates for vitamin D testing will apply\n",
      "to patients at risk of Vitamin D deficiency such as chronic lack of sun\n",
      "exposure.\n",
      "\n",
      "NATA Accreditation No 2178\n",
      "\n",
      "Tests Completed: LFT(s),C(s),UCreat(s),E(s),Glu(s),Phos(s),Iron(s),\n",
      "Lipids HDL(s),Ca(s),Mg(s),Vit D(s),TSH(s),HBsAb(s),\n",
      "HB-Sero, FBC (e) ,RubG(s)\n",
      "\n",
      "Tests Pending\n",
      "\n",
      "Sample Pending\n",
      "\n",
      "removed\n",
      "\n",
      "removed\n",
      "\n",
      "removed\n",
      "\n",
      "remoed\n",
      "\n",
      "Laboratory: dhm\n",
      "\n",
      "removed\n",
      "\n",
      "Copy to:\n",
      "\n",
      "removed\n",
      "\n",
      "Name of Test: Iron Studies\n",
      "\n",
      "removed\n",
      "\f",
      "\n",
      "Requested: 30/01/2024 Collected: 31/01/2024 Reported: 01/02/2024 02:47\n",
      "\n",
      "Clinical notes: pregnancy planning\n",
      "Clinical Notes : pregnancy planning\n",
      "\n",
      "IRON\n",
      "\n",
      "Date 23/12/17 29/01/19 28/07/23 31/01/24\n",
      "\n",
      "Time F-Fast 0825 F 1640 0839 F 0727 F\n",
      "\n",
      "Lab ID 266516640 295348768 885515368 838828312 Units Reference\n",
      "Tron 11.5 12.2 24.9 umol/L (5.0-30.0)\n",
      "Transferrin 2.2 2.5 2.7 g/L (2.0-3.6)\n",
      "TIBC (Calc) 50 56 60 umol/L (46-77)\n",
      "Saturation 23 22 42 % (10-45)\n",
      "Ferritin 38 79 39 47 ug/L (15-200)\n",
      "\n",
      "NATA Accreditation No 2178\n",
      "\n",
      "Tests Completed: LFT(s),C(s),UCreat(s),E(s),Glu(s),Phos(s),Iron(s),\n",
      "Lipids HDL(s),Ca(s),Mg(s),TSH(s),HBsAb(s),HB-Sero,\n",
      "FBC (e) , RubG (s)\n",
      "\n",
      "Tests Pending : Vit D(s)\n",
      "\n",
      "Sample Pending\n",
      "\n",
      "removed\n",
      "\n",
      "removed\n",
      "\n",
      "removed\n",
      "\n",
      "remoed\n",
      "Your Reference: Lab Reference: removed\n",
      "\n",
      "Laboratory: dhm\n",
      "\n",
      "removed\n",
      "\n",
      "Copy to:\n",
      "\n",
      "removed\n",
      "\n",
      "Name of Test: Thyroid Function\n",
      "\n",
      "Requested: 30/01/2024 Collected: 31/01/2024 Reported: 01/02/2024 02:47\n",
      "Clinical notes: pregnancy planning\n",
      "Clinical Notes : pregnancy planning\n",
      "\n",
      "TFT\n",
      "\n",
      "Date 23/12/17 24/09/18 14/08/23 31/01/24\n",
      "\n",
      "Time F-Fast 0825 F 1100 1248 0727 F\n",
      "\n",
      "Lab ID 266516640 282139635 887902883 838828312 Units Reference\n",
      "TSH 1.14 1.18 1.57 2.99 mIU/L (0.40-3.50)\n",
      "\n",
      "NATA Accreditation No 2178\n",
      "\n",
      "Tests Completed: LFT(s),C(s),UCreat(s),E(s),Glu(s),Phos(s),Iron(s),\n",
      "Lipids HDL(s),Ca(s),Mg(s),TSH(s),HBsAb(s),HB-Sero,\n",
      "FBC (e) , RubG (s)\n",
      "\n",
      "Tests Pending : Vit D(s)\n",
      "\n",
      "Sample Pending\n",
      "\n",
      "removed\n",
      "\n",
      "removed\n",
      "\n",
      "removed\n",
      "\n",
      "remoed\n",
      "\n",
      "Laboratory: dhm\n",
      "\n",
      "removed\n",
      "\f",
      "\n",
      "removed\n",
      "\n",
      "Name of Test: _ Pregnancy\n",
      "Requested: 02/02/2024 Collected: 02/02/2024 Reported: 13/02/2024 17:17\n",
      "Clinical notes: NO HISTORY,\n",
      "\n",
      "Clinical Notes : NO HISTORY,\n",
      "\n",
      "HCG / PREGNANCY\n",
      "\n",
      "Date 29/01/19 02/02/24\n",
      "\n",
      "Time 1640 1429\n",
      "\n",
      "Lab ID 295348768 839050249 Units Reference\n",
      "BhcG (Abbott) <5 <5 IU/L\n",
      "\n",
      "Comments on Collection 02/02/24 1429:\n",
      "Expected values for normal pregnancy\n",
      "\n",
      "Gestational age (from LMP) IU/L\n",
      "\n",
      "4 weeks 16 - 160\n",
      "4-5 weeks 100 - 5000\n",
      "5-6 weeks 1000 - 30000\n",
      "6-7 weeks 2500 - 80000\n",
      "7-8 weeks 23000 - 150000\n",
      "8-9 weeks 27000 - 230000\n",
      "9-13 weeks 21000 - 290000\n",
      "2nd trimester 6000 - 100000\n",
      "3rd trimester 3000 - 80000\n",
      "\n",
      "Non Pregnant female - less than 5 IU/L\n",
      "\n",
      "NATA Accreditation No 2178\n",
      "\n",
      "Tests Completed: HCG Quant(s),Ca(s),RU-Malb, PTH(e),MSU,Urinel, Urine2, Urine3\n",
      "Tests Pending\n",
      "Sample Pending\n",
      "\n",
      "removed\n",
      "\n",
      "removed\n",
      "\n",
      "removed\n",
      "\n",
      "remoed\n",
      "Your Reference: Lab Reference: removed\n",
      "\n",
      "Laboratory: dhm\n",
      "\n",
      "removed\n",
      "\n",
      "Name of Test: Biochemistry\n",
      "\n",
      "Requested: 02/02/2024 Collected: 02/02/2024 Reported: 13/02/2024 17:17\n",
      "Clinical notes: NO HISTORY,\n",
      "\n",
      "Clinical Notes : NO HISTORY,\n",
      "\n",
      "BIOCHEMISTRY\n",
      "\n",
      "Date 29/01/19 28/07/23 31/01/24 02/02/24\n",
      "\n",
      "Time F-Fast 1640 0839 F 0727 F 1429\n",
      "\n",
      "Lab ID 295348768 885515368 838828312 839050249 Units Reference\n",
      "Calcium 2.40 2.39 mmol/L (2.15-2.55)\n",
      "Corr Calcium 2.34 2.27 mmol/L (2.15-2.55)\n",
      "Albumin 46 44 46 H 49 g/L (37-48)\n",
      "\n",
      "NATA Accreditation No 2178\n",
      "\n",
      "Tests Completed: HCG Quant(s),Ca(s),RU-Malb, PTH(e),MSU,Urinel, Urine2, Urine3\n",
      "Tests Pending\n",
      "\n",
      "removed\n",
      "\f",
      "\n",
      "Sample Pending\n",
      "\n",
      "removed\n",
      "\n",
      "removed\n",
      "\n",
      "removed\n",
      "\n",
      "remoed\n",
      "Your Reference: Lab Reference: removed\n",
      "\n",
      "Laboratory: dhm\n",
      "\n",
      "removed\n",
      "\n",
      "Name of Test: RU-Malb\n",
      "\n",
      "Requested: 02/02/2024 Collected: 02/02/2024 Reported: 13/02/2024 17:17\n",
      "Clinical notes: NO HISTORY,\n",
      "\n",
      "Clinical Notes : NO HISTORY,\n",
      "\n",
      "Date 14/08/23 02/02/24\n",
      "\n",
      "Time 1248 1429\n",
      "\n",
      "Lab ID 887902883 839050249 Units Reference\n",
      "R U-Creatinine 3.9 4.4 mmol/L\n",
      "\n",
      "R U-Albumin 9.6 5.6 mg/L\n",
      "\n",
      "R U-Alb/Creat 2.5 1.3 mg/mmol (<3.5)\n",
      "\n",
      "NATA Accreditation No 2178\n",
      "\n",
      "Tests Completed: HCG Quant(s),Ca(s),RU-Malb, PTH(e),MSU,Urinel, Urine2, Urine3\n",
      "Tests Pending\n",
      "Sample Pending\n",
      "\n",
      "removed\n",
      "\n",
      "removed\n",
      "\n",
      "removed\n",
      "\n",
      "remoed\n",
      "Your Reference: Lab Reference: removed\n",
      "\n",
      "Laboratory: dhm\n",
      "\n",
      "removed\n",
      "\n",
      "Name of Test: MSU\n",
      "\n",
      "Requested: 02/02/2024 Collected: 02/02/2024 Reported: 13/02/2024 17:17\n",
      "Clinical notes: NO HISTORY,\n",
      "\n",
      "Clinical Notes : NO HISTORY,\n",
      "\n",
      "Urine\n",
      "\n",
      "pH 6 Protein Nil Glucose Nil\n",
      "\n",
      "Blood Trace Ketones Nil\n",
      "\n",
      "Specific gravity 1.007 (1.005 - 1.030)\n",
      "\n",
      "Microscopy\n",
      "\n",
      "Leucocytes 0 x10*6/L ( <10 )\n",
      "Erythrocytes 0 x10*6/L ( <10 )\n",
      "Epithelial cells 5 x10*6/L\n",
      "\n",
      "Culture No growth\n",
      "\n",
      "NATA Accreditation No 2178\n",
      "Tests Completed: HCG Quant(s),Ca(s),RU-Malb, PTH(e),MSU, Urinel, Urine2, Urine3\n",
      "\n",
      "Tests Pending\n",
      "Sample Pending\n",
      "\n",
      "removed\n",
      "\f",
      "\n",
      "removed\n",
      "\n",
      "removed\n",
      "\n",
      "removed\n",
      "\n",
      "remoed\n",
      "Your Reference: Lab Reference: 8removed\n",
      "\n",
      "Laboratory: dhm\n",
      "\n",
      "removed\n",
      "\n",
      "Name of Test: Biochemistry\n",
      "\n",
      "Requested: 05/02/2024 Collected: 05/02/2024 Reported: 13/02/2024 17:17\n",
      "Clinical notes: NO HISTORY\n",
      "\n",
      "Clinical Notes : NO HISTORY\n",
      "\n",
      "BIOCHEMISTRY\n",
      "\n",
      "Date 14/08/23 31/01/24 02/02/24 05/02/24\n",
      "\n",
      "Time F-Fast 1248 O727 F 1429 1341\n",
      "\n",
      "Lab ID 887902883 838828312 839050249 838828414 Units Reference\n",
      "Status Fasting Random\n",
      "\n",
      "Sodium 139 140 138 mmol/L (135-145)\n",
      "Potassium 4.8 4.5 4.5 mmol/L (3.5-5.5)\n",
      "Chloride 107 106 108 mmol/L (95-110)\n",
      "Bicarbonate 21 25 23 mmol/L (20-32)\n",
      "Urea 5.3 5.1 5.2 mmol/L (2.5-7.0)\n",
      "Creatinine 65 65 70 umol/L (45-85)\n",
      "eGFR >90 >90 >90 mL/min/1.73m2 (>59)\n",
      "Urate 0.20 0.21 mmol/L (0.15-0.40)\n",
      "Calcium 2.40 2.39 2.37 mmol/L (2.15-2.55)\n",
      "Corr Calcium 2.34 2.27 2.33 mmol/L (2.15-2.55)\n",
      "Phosphate. 1.08 1.06 mmol/L (0.8-1.5)\n",
      "Bili.Total H 18 10 umol/L (3-15)\n",
      "\n",
      "ALP 70 68 U/L (20-105)\n",
      "GGT 15 14 U/L (5-35)\n",
      "\n",
      "LD 178 185 U/L (120-250)\n",
      "AST 23 18 U/L (10-35)\n",
      "\n",
      "ALT 22 15 U/L (5-30)\n",
      "Total Protein 72 70 g/L (68-85)\n",
      "Albumin 46 H 49 45 g/L (37-48)\n",
      "Globulin 26 25 g/L (23-39)\n",
      "Cholesterol 4.7 4.2 mmol/L (<5.5)\n",
      "Triglycerides 0.6 0.9 mmol/L (<2.0)\n",
      "\n",
      "Comments on Collection 05/02/24 1341:\n",
      "eGFR (mL/min/1.73m2) calculated by CKD-EPI formula - see www.kidney.org.au\n",
      "\n",
      "NATA Accreditation No 2178\n",
      "\n",
      "Tests Completed: LFT(s),Lipids(s),C(s),UCreat(s),E(s),Glu(s),Phos(s),\n",
      "UA(s),Lipids HDL(s),Ca(s)\n",
      "\n",
      "Tests Pending\n",
      "\n",
      "Sample Pending\n",
      "\n",
      "removed\n",
      "\n",
      "removed\n",
      "\n",
      "removed\n",
      "\n",
      "remoed\n",
      "Your Reference: Lab Reference: removed\n",
      "\n",
      "Laboratory: dhm\n",
      "\n",
      "removed\n",
      "\n",
      "Name of Test: PTH (e)\n",
      "\n",
      "Requested: 02/02/2024 Collected: 05/02/2024 Reported: 13/02/2024 17:17\n",
      "\n",
      "removed\n",
      "\f",
      "\n",
      "Clinical notes: NO HISTORY,\n",
      "\n",
      "Clinical Notes : NO HISTORY,\n",
      "\n",
      "Parathyroid Hormone\n",
      "(Intact (1-84) PTH measured by Roche method.)\n",
      "\n",
      "Intact Parathyroid Hormone 3.5 pmol/L ( 1.6 - 6.9 )\n",
      "Calcium 2.39 mmol/L ( 2.15 - 2.55 )\n",
      "Corrected Calcium 2.27 mmol/L ( 2.15 - 2.55 )\n",
      "Albumin H 49 g/L ( 37 - 48 )\n",
      "\n",
      "Comment on Lab ID 839050249\n",
      "\n",
      "# Please note PTH(e) collection date: 05/02/2024 13:43\n",
      "\n",
      "NATA Accreditation No 2178\n",
      "\n",
      "Tests Completed: HCG Quant(s),Ca(s),RU-Malb, PTH(e),MSU,Urinel, Urine2, Urine3\n",
      "Tests Pending\n",
      "Sample Pending\n",
      "\n",
      "removed\n",
      "\n",
      "removed\n",
      "\n",
      "removed\n",
      "\n",
      "remoed\n",
      "Your Reference: Lab Reference: removed\n",
      "\n",
      "Laboratory: dhm\n",
      "\n",
      "removed\n",
      "\n",
      "Name of Test: _Glucose\n",
      "\n",
      "Requested: 05/02/2024 Collected: 05/02/2024 Reported: 13/02/2024 17:17\n",
      "Clinical notes: NO HISTORY\n",
      "\n",
      "Clinical Notes : NO HISTORY\n",
      "\n",
      "GLUCOSE\n",
      "\n",
      "Date 24/09/18 28/07/23 31/01/24 05/02/24\n",
      "\n",
      "Time F-Fast 1100 0839 F Q727 F 1341\n",
      "\n",
      "Lab ID 282139635 885515368 838828312 838828414 Units Reference\n",
      "F Gluc Plasma 4.7 mmol/L (3.6-6.0)\n",
      "R Gluc Plasma 4.5 mmol/L (3.6-7.8)\n",
      "F Gluc Serum 4.8 mmol/L (3.6-6.0)\n",
      "R Gluc Serum 5.5 mmol/L (3.6-7.7)\n",
      "\n",
      "NATA Accreditation No 2178\n",
      "\n",
      "Tests Completed: LFT(s),Lipids(s),C(s),UCreat(s),E(s),Glu(s),Phos(s),\n",
      "UA(s),Lipids HDL(s),Ca(s)\n",
      "\n",
      "Tests Pending\n",
      "\n",
      "Sample Pending\n",
      "\n",
      "removed\n",
      "\n",
      "removed\n",
      "\n",
      "removed\n",
      "\n",
      "remoed\n",
      "\n",
      "Laboratory: dhm\n",
      "\n",
      "removed\n",
      "\n",
      "Name of Test: Lipids HDL(s)\n",
      "\n",
      "removed\n",
      "\f",
      "\n",
      "Requested: 05/02/2024 Collected: 05/02/2024 Reported: 13/02/2024 17:17\n",
      "\n",
      "Clinical notes: NO HISTORY\n",
      "\n",
      "Clinical Notes : NO HISTORY\n",
      "\n",
      "Date 23/12/17 31/01/24 05/02/24\n",
      "\n",
      "Time F-Fast 0825 F O727 F 1341\n",
      "\n",
      "Lab ID 266516640 838828312 838828414 Units Reference\n",
      "Status Fasting Fasting Random\n",
      "\n",
      "Cholesterol L 3.8 4.7 4.2 mmol/L (<5.5)\n",
      "Triglycerides 0.5 0.6 0.9 mmol/L (<2.0)\n",
      "HDL Chol. 1.6 2.0 1.6 mmol/L (>1.2)\n",
      "LDL Chol. 2.0 2.4 2.2 mmol/L (<3.0)\n",
      "Non-HDL Chol. 2.7 2.6 mmol/L (<4.0)\n",
      "\n",
      "Comments on Collection 05/02/24 1341:\n",
      "\n",
      "Please note that the above reference limits are decision limits.\n",
      "\n",
      "A flag based on these limits is an indication to review the absolute\n",
      "cardiovascular risk for the patient. For assessment of absolute\n",
      "cardiovascular disease risk please see www.cvdcheck.org.au\n",
      "\n",
      "The above decision limits are based on the European Atherosclerosis Society\n",
      "(EAS) and European Federation of Clinical Chemistry and Laboratory Medicine\n",
      "(EFLM) Consensus Statement 2016 and the Australasian Association of\n",
      "Clinical Biochemistry and Laboratory Medicine (AACB) Lipid Reporting\n",
      "Guideline 2018.\n",
      "\n",
      "Lipid treatment targets for patients at high risk of cardiovascular\n",
      "\n",
      "disease:\n",
      "\n",
      "Total cholesterol <4.0 mmol/L\n",
      "\n",
      "Triglyceride <2.0 mmol/L\n",
      "\n",
      "HDL cholesterol >1.0 mmol/L\n",
      "\n",
      "LDL cholesterol <2.5 mmol/L (<1.8 mmol/L for very high risk)\n",
      "Non-HDL cholesterol <3.3 mmol/L (<2.5 mmol/L for very high risk)\n",
      "High risk - Primary prevention Very high risk - Secondary prevention\n",
      "\n",
      "Target values from the AACB Lipid Reporting Guideline 2018.\n",
      "\n",
      "Please note that as there is a continuum of risk, benefits are obtained for\n",
      "any measured lipid components moving towards and beyond the various target\n",
      "levels.\n",
      "\n",
      "NATA Accreditation No 2178\n",
      "\n",
      "Tests Completed: LFT(s),Lipids(s),C(s),UCreat(s),E(s),Glu(s),Phos(s),\n",
      "UA(s),Lipids HDL(s),Ca(s)\n",
      "\n",
      "Tests Pending\n",
      "\n",
      "Sample Pending\n",
      "\n",
      "removed\n",
      "\n",
      "removed\n",
      "\n",
      "removed\n",
      "\n",
      "remoed\n",
      "\n",
      "Laboratory: dhm\n",
      "\n",
      "removed\n",
      "Copy to:\n",
      "\n",
      "removed\n",
      "DR TIN KHIN\n",
      "DR SHAHEEN NAWAZ\n",
      "\n",
      "Name of Test: BP Monitor\n",
      "Requested: 03/02/2024 Collected: 06/02/2024 Reported: 13/02/2024 17:17\n",
      "Clinical notes: ? HYPERTENSION ?ANXIETY RELATED/WHITE COAT HYPERTENSION (NEEDS EXCLUDING)\n",
      "\n",
      "removed\n",
      "\f",
      "\n",
      "Clinical Notes : ? HYPERTENSION ?ANXIETY RELATED/WHITE COAT\n",
      "HYPERTENSION (NEEDS EXCLUDING)\n",
      "\n",
      "Ambulatory Blood Pressure Monitoring\n",
      "\n",
      "Start date and time 05/02/2024 13:52\n",
      "End date and time 06/02/2024 13:00\n",
      "Medications Please refer to patient diary for\n",
      "\n",
      "current medications.\n",
      "\n",
      "Average BP 127/85 mmHg (N.R. <130/80)\n",
      "Day\n",
      "Average BP 130/89 mmHg (N.R. <135/85)\n",
      "Night\n",
      "Average BP 120/72 mmHg (N.R. <120/75)\n",
      "Report Borderline hypertension. Non Dipper.\n",
      "\n",
      "Dr. Joseph Chiha\n",
      "\n",
      "Reported by Dr. Joseph Chiha\n",
      "Date reported 06/02/2024\n",
      "\n",
      "Comment on Lab ID 839308720\n",
      "\n",
      "The report above is based on a non-pregnant individual with no risk\n",
      "factors. The results need to be correlated with the individual's clinical\n",
      "background.\n",
      "\n",
      "The National Heart Foundation and High Blood Pressure Research Council of\n",
      "Australia Ambulatory Blood Pressure Committee guidelines (2012) stipulate\n",
      "the hypertensive threshold be lower for the following groups:\n",
      "\n",
      "1. People with associated clinical conditions or end-organ damage\n",
      "24 hour 125/76 Night 112/67 Day 128/78\n",
      "2. Hypertension with proteinuria >l g per day\n",
      "24 hour 121/71 Night 107/63 Day 124/74\n",
      "3. Pregnancy <22 weeks gestation 132/79\n",
      "\n",
      "22-30 weeks gestation 133/81\n",
      ">30 weeks gestation 135/86\n",
      "\n",
      "Reference: Head GA. et al Ambulatory blood pressure monitoring in\n",
      "Australia: 2011 consensus position statement. J Hypertens. 2012\n",
      "Feb; 30 (2) :253-66.)\n",
      "\n",
      "To access a PDF version of the report, copy and paste the URL below into your browser\n",
      "\n",
      "before 12-02-2025. Use PIN 7661.\n",
      "\n",
      "https://sdrviewer.apps.sonichealthcare.com/ ?GUID=FD73BA43-AE9C-4FA1-B54A-5A721557B246éhostCode=D\n",
      "HM&shareType=1l\n",
      "\n",
      "NATA Accreditation No 2178\n",
      "Tests Completed: BP Monitor\n",
      "\n",
      "Tests Pending\n",
      "Sample Pending\n",
      "\n",
      "removed\n",
      "\n",
      "removed\n",
      "\n",
      "removed\n",
      "\n",
      "remoed\n",
      "\n",
      "Laboratory: dhm\n",
      "\n",
      "removed\n",
      "\n",
      "removed\n",
      "\f",
      "\n",
      "Copy to:\n",
      "removed\n",
      "DR TIN KHIN\n",
      "DR SHAHEEN NAWAZ\n",
      "\n",
      "Name of Test: BP Monitor\n",
      "Requested: 03/02/2024 Collected: 06/02/2024 Reported: 06/02/2024 17:17\n",
      "Clinical notes: 2? HYPERTENSION ?ANXIETY RELATED/WHITE COAT HYPERTENSION (NEEDS EXCLUDING)\n",
      "\n",
      "Clinical Notes : ? HYPERTENSION ?ANXIETY RELATED/WHITE COAT\n",
      "HYPERTENSION (NEEDS EXCLUDING)\n",
      "\n",
      "Ambulatory Blood Pressure Monitoring\n",
      "\n",
      "Start date and time 05/02/2024 13:52\n",
      "End date and time 06/02/2024 13:00\n",
      "Medications Please refer to patient diary for\n",
      "\n",
      "current medications.\n",
      "\n",
      "Average BP 127/85 mmHg (N.R. <130/80)\n",
      "Day\n",
      "Average BP 130/89 mmHg (N.R. <135/85)\n",
      "Night\n",
      "Average BP 120/72 mmHg (N.R. <120/75)\n",
      "Report Borderline hypertension. Non Dipper.\n",
      "\n",
      "Dr. Joseph Chiha\n",
      "\n",
      "Reported by Dr. Joseph Chiha\n",
      "\n",
      "Date reported 06/02/2024\n",
      "\n",
      "Comment on Lab ID 839308720\n",
      "\n",
      "The report above is based on a non-pregnant individual with no risk\n",
      "factors. The results need to be correlated with the individual's clinical\n",
      "background.\n",
      "\n",
      "The National Heart Foundation and High Blood Pressure Research Council of\n",
      "\n",
      "Australia Ambulatory Blood Pressure Committee guidelines (2012) stipulate\n",
      "the hypertensive threshold be lower for the following groups:\n",
      "\n",
      "1. People with associated clinical conditions or end-organ damage\n",
      "24 hour 125/76 Night 112/67 Day 128/78\n",
      "2. Hypertension with proteinuria >l g per day\n",
      "24 hour 121/71 Night 107/63 Day 124/74\n",
      "3. Pregnancy <22 weeks gestation 132/79\n",
      "\n",
      "22-30 weeks gestation 133/81\n",
      ">30 weeks gestation 135/86\n",
      "\n",
      "Reference: Head GA. et al Ambulatory blood pressure monitoring in\n",
      "Australia: 2011 consensus position statement. J Hypertens. 2012\n",
      "Feb; 30 (2) :253-66.)\n",
      "\n",
      "To access a PDF version of the report, copy and paste the URL below into your browser\n",
      "\n",
      "before 05-02-2025. Use PIN 1919.\n",
      "https://sdrviewer.apps.sonichealthcare.com/ ?GUID=F74026BF-2 6 4A-4 9E9-8CF4-7025DBD8C5E5 éhostCode=D\n",
      "HMé&shareType=l\n",
      "\n",
      "NATA Accreditation No 2178\n",
      "Tests Completed: BP Monitor\n",
      "\n",
      "Tests Pending\n",
      "Sample Pending\n",
      "\n",
      "removed\n",
      "\f",
      "\n",
      "removed\n",
      "\n",
      "removed\n",
      "\n",
      "removed\n",
      "\n",
      "remoed\n",
      "Your Reference: 15992986 Lab Refremoved\n",
      "\n",
      "Laboratory: PRP Diagnostic Imaging\n",
      "\n",
      "removed\n",
      "\n",
      "Name of Test: US RENAL\n",
      "\n",
      "Requested: 02/02/2024 Collected: 10/02/2024 Reported: 10/02/2024 10:46\n",
      "\n",
      "removed\n",
      "removed\n",
      "==\" ” Oo DOB:19/01/1989 Phone:\n",
      "wm Pe Gender :F Medicare Number:\n",
      "Click here to view images\n",
      "removed\n",
      "\n",
      "Referred By: -:\n",
      "Dr S. NAWAZ\n",
      "\n",
      "Copies:\n",
      "removed\n",
      "\n",
      "US RENAL 10/02/2024 Reference: 15992986\n",
      "ULTRASOUND URINARY TRACT\n",
      "\n",
      "HISTORY:\n",
      "Persistent Haematuria.\n",
      "\n",
      "COMPARISON:\n",
      "None available.\n",
      "\n",
      "FINDINGS:\n",
      "Right Kidney: 100 mm in length. There is no hydronephrosis, calculus\n",
      "or renal mass.\n",
      "\n",
      "Left Kidney: 104 mm in length. There is no hydronephrosis, calculus\n",
      "or renal mass.\n",
      "\n",
      "Bladder: Prevoid volume: 195 mL. Postvoid volume: 10 mL. The bladder\n",
      "is normal. Both ureteric jets were seen.\n",
      "\n",
      "COMMENT:\n",
      "No renal tract abnormality identified.\n",
      "\n",
      "Dr Mark Fiorentino\n",
      "\n",
      "Electronically verified by: Dr Mark Fiorentino - 10/02/2024 10:43\n",
      "\n",
      "Fully Rebatable 1.5T and 3T MRI - Same day appointments available at\n",
      "PRP Orange\n",
      "Click here to view images\n",
      "\n",
      "removed\n",
      "\n",
      "removed\n",
      "\f",
      "\n",
      "removed\n",
      "\n",
      "removed\n",
      "\n",
      "remoed\n",
      "Your Reference: 15992986 Lab Refremoved\n",
      "\n",
      "Laboratory: PRP Diagnostic Imaging\n",
      "\n",
      "removed\n",
      "\n",
      "Name of Test: US RENAL\n",
      "\n",
      "Requested: 02/02/2024 Collected: 10/02/2024 Reported: 10/02/2024 10:46\n",
      "\n",
      "removed\n",
      "removed\n",
      "=—_—— — ; .. 7 DOB:19/01/1989 Phone:\n",
      "ns Gender: F Medicare Number:\n",
      "Click here to view images\n",
      "removed\n",
      "\n",
      "Referred By: -:\n",
      "Dr S. NAWAZ\n",
      "\n",
      "Copies:\n",
      "removed\n",
      "\n",
      "US RENAL 10/02/2024 Reference: 15992986\n",
      "ULTRASOUND URINARY TRACT\n",
      "\n",
      "HISTORY:\n",
      "Persistent Haematuria.\n",
      "\n",
      "COMPARISON:\n",
      "None available.\n",
      "\n",
      "FINDINGS:\n",
      "Right Kidney: 100 mm in length. There is no hydronephrosis, calculus\n",
      "or renal mass.\n",
      "\n",
      "Left Kidney: 104 mm in length. There is no hydronephrosis, calculus\n",
      "or renal mass.\n",
      "\n",
      "Bladder: Prevoid volume: 195 mL. Postvoid volume: 10 mL. The bladder\n",
      "is normal. Both ureteric jets were seen.\n",
      "\n",
      "COMMENT :\n",
      "No renal tract abnormality identified.\n",
      "\n",
      "Dr Mark Fiorentino\n",
      "\n",
      "Electronically verified by: Dr Mark Fiorentino - 10/02/2024 10:43\n",
      "\n",
      "Fully Rebatable 1.5T and 3T MRI - Same day appointments available at\n",
      "PRP Orange\n",
      "Click here to view images\n",
      "\n",
      "removed\n",
      "removed\n",
      "removed\n",
      "\n",
      "removed\n",
      "\f",
      "\n",
      "------------------------------------- End record ----------------------------------\n",
      "\n",
      "\n",
      "\n",
      "------------------------------------- Start record --------------------------------\n",
      "\n",
      "\n",
      " \n",
      "\n",
      " \n",
      "\n",
      "  \n",
      " \n",
      "  \n",
      " \n",
      " \n",
      " \n",
      " \n",
      "\n",
      "29 APR\n",
      "\n",
      "   \n",
      "\n",
      "MRN:\n",
      "Name:\n",
      "\n",
      "Ph:\n",
      "Age:\n",
      "\n",
      "      \n",
      "     \n",
      "\n",
      "    \n",
      " \n",
      "\n",
      " \n",
      "\n",
      "64+ Yrs DOB:  Sex: Male\n",
      "\n",
      "Notes: ? ANAEMIC\n",
      "\n",
      "( CHEMISTRY\n",
      "\n",
      "~\n",
      "\n",
      "\n",
      "Result PLEVicus resuits Fox, comparison omy\n",
      "Date: 26/94/19 noe ference\n",
      "Time: 15:40 V£or this\n",
      "Request No.:  Units collecrion)\n",
      "\n",
      "Electrolytes (serum/plasma)\n",
      "\n",
      "Sodium 142 mmol/L [185-145]\n",
      "Potassium 4.0 mmol/L (2.5-5.2]\n",
      "Chloride 106 mmol/L [95-110]\n",
      "Bicarbonate 28 mmol/L [22-32]\n",
      "Urea 4.1 mmol/L [4.0-9.0]\n",
      "Creatinine 89 umol/L [60-110]\n",
      "eGFR 79 mL/mn/1.73m2[>60]\n",
      "\n",
      "Uric acid 0.44 mmol/L [0.25-0.50]\n",
      "Calcium 2.40 mmol/L [2.10-2.60]\n",
      "Calcium (corr. Alb) 2.40 mmol/L [2.10-2.60]\n",
      "Magnesium 0.81 mmol/L [0.70-1.10]\n",
      "Inorganic Phosphate 1.12 mmol/L [0.70-1.50]\n",
      "eGFR comment gfrmild\n",
      "\n",
      "Range Comment COM1\n",
      "\n",
      "Comments: (26/04/2019 15:40 Episode No. )\n",
      "\n",
      "\n",
      "\n",
      "------------------------------------- End record ----------------------------------\n",
      "\n",
      "\n",
      "\n",
      "------------------------------------- Start record --------------------------------\n",
      " \n",
      "\n",
      "HAEMATOLOGY\n",
      "\n",
      " \n",
      "15\n",
      "BLOOD - EDTA Result Range Units\n",
      "\n",
      "ESR 2 0-20 mm/h @\n",
      "\n",
      "FULL BLOOD EXAMINATION\n",
      "HAEMOGLOBIN 122 110-150 g/L a @ a\n",
      "Erythrocytes (RBCs) 46 42-56 i | e a\n",
      "Mean Cell Volume 102.0*H 78.0-98.0 — f a di\n",
      "Mean Cell Hb 27.0 26.0-34.0 pg a @ a\n",
      "MCHC 29.0*L 31.0-370 pol fe a\n",
      "Haematocrit 47.0 35.0 - 47.0 % a @ a\n",
      "PLATELETS 338 150 - 450 ‘oro. i e a\n",
      "LEUCOCYTES (WBCs) 7.3 4.0- 11.0 1049/L a @ a\n",
      "Neutrophils 4.8 2.0-7.5 1o.o/L @ a\n",
      "Lymphocytes 1.8 1.0-4.0 a | @ a\n",
      "Monocytes 0.5 0.0 - 1.0 1049/L @ pe\n",
      "Eosinophils 0.2 0.0 - 0.6 1049/L e ||\n",
      "Basophils 0.1 0.0 - 0.2 1049/L @ p\n",
      "RDW 15.6*H 11.0- 15.5 percent [ij e\n",
      "\n",
      "Film Comment\n",
      "\n",
      "Test performed by accredited laboratory NATA: \n",
      "\n",
      "\n",
      " \n",
      "\n",
      "BLOOD - SERUM Result Range Units\n",
      "\n",
      "UEC (Renal)\n",
      "SODIUM 138 135 - 145 mmol/L e@ a\n",
      "POTASSIUM 4.5 3.5 - 5.2 mmol/L e a\n",
      "CHLORIDE 102 95-110 mmol/L e a\n",
      "BICARBONATE 24 20 - 32 mmol/L e a\n",
      "Anion Gap 16 8-16 mmol/L e a\n",
      "UREA 3.7 2.5-7.0 mmol/L e@ a\n",
      "CREATININE (mmol/L) 0.06 0.05 - 0.10 mmol/L e@ a\n",
      "Creatinine 62 45 - 90 umol/L e@ a\n",
      "\n",
      "Estimated GFR >90 > 90 ml/min/1 ___- e\n",
      "\n",
      " \n",
      "\n",
      "*) Result outside normal reference range H) Result is above upper limit of reference rang (L) Result is below lower limit of reference range\n",
      "\n",
      " \n",
      "\f",
      "\n",
      " \n",
      "\n",
      "UEC Comment\n",
      "\n",
      "ELEVATED ANION GAP:\n",
      "\n",
      "An elevated anion gap indicates metabolic acidosis. In uncontrolled diabetes, there is\n",
      "an increase in ketoacids due to metabolism of ketones. In these conditions, bicarbonate\n",
      "concentrations decrease by acting as a buffer against the increased presence of acids\n",
      "(as a result of the underlying condition). The bicarbonate is consumed resulting in a\n",
      "high anion gap.\n",
      "\n",
      "ESTIMATED GFR COMMENT:\n",
      "eGFR (mL/min/1.73m2) is calculated by the laboratory using the CKD-EPI formula\n",
      "eGFR > 90 mL/min/1.73 sq.m —- Normal GFR\n",
      "\n",
      "LIVER FUNCTION TESTS\n",
      "\n",
      "BILIRUBIN (TOTAL) 13 0-20 umol/L e |\n",
      "ALP 97 30 - 110 units/L @ a\n",
      "GGT 23 5 - 35 units/L @ a\n",
      "ALT 33 10-35 units/L a @ a\n",
      "AST 25 10-35 units/L a r a\n",
      "PROTEIN - TOTAL 69 60-80 g/L a @ a\n",
      "ALBUMIN 35 33-48 g/L a e a\n",
      "GLOBULIN 33 26-39 g/L a @ a\n",
      "Corrected Calcium Profile\n",
      "CALCIUM 2.36 215-260 mmol/L Jy e a\n",
      "Calcium Adjusted 2.46 210-260 mmol/L e a\n",
      "PHOSPHATE 1.1 06-14 mmol/L i e a\n",
      "MAGNESIUM 0.77. 070-110 mm e a\n",
      "LDH 169 120-250 units/L @ a\n",
      "URATE 0.330 015-040 mmol e a\n",
      "IRON STUDIES\n",
      "IRON 7.8 5.0-30.0 umo/L e a\n",
      "TRANSFERRIN 28 18-35 g/L a e a\n",
      "Transferrin Saturation 77*L 15-45 %o a @ a\n",
      "FERRITIN 32 30-150 ug/L sos e a\n",
      "\n",
      "(*) Result outside normal reference range (H) Result is above upper limit of reference rang (L) Result is below lower limit of reference range\n",
      "\f",
      "\n",
      " \n",
      "\n",
      "Iron Studies Comment\n",
      "\n",
      "Certain medications may affect results. Please correlate clinically.\n",
      "For assistance, please refer to the Iron Studies Interpretation Table below:\n",
      "\n",
      "| CONDITION/SYMPTOM | IRON | TRANSFERRIN SATURATION | FERRITIN |\n",
      "| Inon Deficiency | Decreased | Decreased ——'||-:‘Decreased =|\n",
      "| Iron Deficiency and | | Normal or |. \"Normal\" =|\n",
      "| Acute Phase Response | Decreased | Decreased | <100 ug/L |\n",
      "| Acute Phase Response | Decreased | Decreased -—«'||:“*Increased =|\n",
      "| ‘Tron Overload —«||.:«Increased | ~—‘ Increased =—S—=|sIncreased =|\n",
      "\n",
      "FERRITIN COMMENT :\n",
      "Serum ferritin levels >30 pg/L demonstrates healthy iron stores as long as co-existing\n",
      "inflammatory disease or hepatocellular damage are not present.\n",
      "\n",
      "25 OH VITAMIN D 77. 50-200 nmol/L i e a\n",
      "Vitamins Comment\n",
      "\n",
      "VITAMIN D COMMENT:\n",
      "Levels above 75 nmol/L may be desirable in people with osteoporosis or falls.\n",
      "25-hydroxy Vitamin D represents the body's stores/reserves level.\n",
      "\n",
      "Vitamin D Deficiency Interpretation:\n",
      "\n",
      "Mild: 30-49 nmol/l\n",
      "Moderate: 12.5-29 nmol/1\n",
      "Severe: <12.5 nmol/l\n",
      "\n",
      "(“) Result outside normal reference range (H) Result is above upper limit of reference rang (L) Result is below lower limit of reference range\n",
      "\n",
      " \n",
      "\f",
      "\n",
      " \n",
      "\n",
      "LIPIDS\n",
      "\n",
      " \n",
      "\n",
      " \n",
      "\n",
      "CHOLESTEROL 5.0 0.0 - 5.5 mmol/L @\n",
      "TRIGLYCERIDES 2.8*H 0.0- 2.0 mmol/L\n",
      "LIPID STUDIES\n",
      "HDL(Protective) 0.8*L 1.2-2.0 mmol/L He\n",
      "Non-HDL Cholesterol 4.23*H <4.0 mmol/L ry\n",
      "LDL(Atherogenic) 3.0 0.0 - 3.4 mmol/L e\n",
      "Cholesterol/HDL Ratio 6.6\n",
      "LDL/HDL RATIO (Risk Factor) 3.9*H 0.0-3.2\n",
      "Trig/HDL Ratio 3.7*H 0.5-1.7 RATIO a\n",
      "(*) Result outside normal reference range (H) Result is above upper limit of reference rang (L) Result is below lower limit of reference range\n",
      "\f",
      "\n",
      " \n",
      "\n",
      "Lipid Profile Comment\n",
      "\n",
      "Target Levels for the general population and the National Vascular Disease Prevention\n",
      "Alliance (NVDPA) treatment target levels for high-risk people (known coronary heart and\n",
      "other arterial diseases, diabetes, chronic renal failure, Aboriginal and Torres Strait\n",
      "Islander peoples and familial hyperlipidaemic conditions) are:\n",
      "\n",
      "Tot. Cholesterol LDL-Cholesterol HDL-Cholesterol\n",
      "General population: <5.5 mmol/L <2.0 mmol/L M: >=1.0, F: >=1.2 mmol/L\n",
      "At risk individuals: <4.0 mmol/L <1.8 mmol/L\n",
      "Fasting Triglycerides: <2.0 mmol/L\n",
      "Non-HDL Cholesterol: <2.5 mmol/L\n",
      "\n",
      "National guidelines generally specify specific targets, refer to www.cvdcheck.org.au\n",
      "\n",
      "ELEVATED TRIGLYCERIDES:\n",
      "\n",
      "Increased levels are seen in primary hypertriglyceridaemic states, and secondary to\n",
      "Nephrotic syndrome, Hypothyroidism, Pancreatitis, Diabetes mellitus, Alcoholism, oral\n",
      "contraceptive use or corticosteroid medication.\n",
      "\n",
      "LOW HDL-CHOLESTEROL :\n",
      "\n",
      "Low levels of HDL cholesterol and high levels of LDL cholesterol are associated with an\n",
      "increased risk of atherosclerotic vascular disease.\n",
      "\n",
      "Further assessment through Liposcreen LDL (Lipid) Subfractions to determine any other\n",
      "lipid anomalies.\n",
      "\n",
      "ELEVATED NON-HDL CHOLESTEROL LEVEL:\n",
      "\n",
      "Non-HDL cholesterol surpasses LDL cholesterol as a risk factor for CVD. Increased\n",
      "non-HDL Cholesterol is a significant marker for subclinical atherosclerosis.\n",
      "Non-HDL Cholesterol >7.5mmol/L indicates an Increased risk of Familial\n",
      "Hypercholesterolaemia.\n",
      "\n",
      "TRIG/HDL RATIO COMMENT:\n",
      "\n",
      "HDL is closely related to triglycerides. Commonly, patients with elevated triglycerides\n",
      "also have low HDL levels, along with elevated clotting factor levels.\n",
      "\n",
      "The triglyceride/HDL ratio is found to be one of the better predictors of heart\n",
      "disease. Research shows that people with an elevated triglyceride/HDL have 16 times the\n",
      "risk of heart attack as those with a low/normal ratio. Therefore, in adults, the\n",
      "triglyceride/HDL ratio should ideally be below 2.0\n",
      "\n",
      "TRIG/HDL Reference Range:\n",
      "\n",
      "< 0.9 Considered ideal (minimal risk)\n",
      "\n",
      "> 1.7 High (moderate risk)\n",
      "\n",
      "> 2.6 Very High (high risk)\n",
      "\n",
      "GLUCOSE (FASTING) 6.6*H 3.0-5.4 mmol/L a He\n",
      "(“) Result outside normal reference range (H) Result is above upper limit of reference rang (L) Result is below lower limit of reference range\n",
      "\f",
      "\n",
      " \n",
      "\n",
      "Glucose Comment\n",
      "\n",
      "ELEVATED FASTING GLUCOSE:\n",
      "\n",
      "Certain medications may affect results. Please correlate clinically.\n",
      "\n",
      "In patients with fasting plasma glucose levels between 5.6-6.9 mmol/L or random plasma\n",
      "glucose levels between 7.8-11.0 mmol/L, an oral Glucose Tolerance Test (GTT) should be\n",
      "performed if the patient is at high risk for diabetes.\n",
      "\n",
      "Irrespective of any GTT results, a fasting plasma glucose 6.1-6.9 mmol/L indicates\n",
      "Impaired Fasting Glucose.\n",
      "\n",
      "In a patient with symptoms suggestive of Diabetes mellitus, the finding of a fasting\n",
      "plasma glucose of > 7.0 mmol/L at least two hours following a meal, is diagnostic of\n",
      "Diabetes mellitus. The finding of either of these levels on two occasions, even in the\n",
      "absence of symptoms, is also diagnostic of Diabetes mellitus.\n",
      "\n",
      "INSULIN (FASTING) 34.1*H 0.0- 17.0 mU/L ile\n",
      "HOMA Score 10.0*H 0.0-2.5 RATIO ile\n",
      "Insulin Tolerance Test Comment\n",
      "\n",
      "FASTING INSULIN Comment:\n",
      "\n",
      "This reference interval is for fasting, normoglycaemic and non-obese population.\n",
      "\n",
      "A fasting glucose should be performed together with fasting insulin to ascertain the\n",
      "HOMA score.\n",
      "\n",
      "The HOMA score is a standard measure of insulin resistance, It is calculated as\n",
      "follows; (Blood Glucose X Fasting Insulin) / 22.5.\n",
      "\n",
      "HOMA Resistance Grade\n",
      "\n",
      "<= 2.0 Normal\n",
      "\n",
      "2.1 - 2.2 Borderline\n",
      "\n",
      "2.3 - 3.0 Moderate\n",
      "\n",
      ">= 3.1 Severe\n",
      "\n",
      "BLOOD - EDTA\n",
      "\n",
      "GLYCOSYLATED HB 5.9*H 4.4-5.6 % a ai\n",
      "\n",
      "Glycated Haemoglobin Comment GLYCOSYLATED HAEMOGLOBIN COMMENT:\n",
      "The goal of diabetes therapy should be a glycated haemoglobin (HbA Ic) level of <7%.\n",
      "The treatment level should be re-evaluated if the HbAIc level is > 8%.\n",
      "\n",
      "ENDOCRINOLOGY\n",
      "\n",
      "BLOOD - SERUM Result Range Units\n",
      "THYROID FUNCTION ASSESSMENT\n",
      "TSH 2.36  0.50-5.00 mU/L e a\n",
      "FREE T4 16.9 12.0 - 22.0 pmol/L a e@ a\n",
      "FREE T3 6.3 3.1 - 6.8 pmolL e@ a\n",
      "Reverse T3 545.0*H 230.0-540.0 pmol/L e\n",
      "FT3 : Reverse T3 Ratio ( X 100) 1.161 *L 1.200 - 2.200 a e a\n",
      "(“) Result outside normal reference range (H) Result is above upper limit of reference rang (L) Result is below lower limit of reference range\n",
      "\f",
      "\n",
      " \n",
      "\n",
      "THYROID TEST COMMENTS\n",
      "\n",
      "TSH has been adopted as the initial test of a thyroid function. Certain medications and\n",
      "conditions may affect results. Please correlate clinically. Repeat testing in 6-8 weeks\n",
      "if clinically indicated.\n",
      "\n",
      "Reference ranges developed using populations without thyroid disease suggest that the\n",
      "optimal TSH range for thyroid function should be 0.5-2.0OmIU/L.\n",
      "\n",
      "FREE T4 and FREE T3\n",
      "\n",
      "Free T4 and T3 represent bioactive portion of thyroid hormone. The test results can\n",
      "identify functional or subclinical hyper- and hypothyroidism and overt hypo- and\n",
      "hyperthyroidism. T4 converts to active T3 or inactive rT3.\n",
      "\n",
      "The results should always be interpreted in association with TSH.\n",
      "\n",
      "REVERSE T3 levels can increase when peripheral conversion of T4 to active T3 is\n",
      "impaired. Peripheral thyroid imbalances may arise from nutrient deficiencies, heavy\n",
      "metal exposure, adrenal stress, enzyme deficiencies, and chronic illnesses.\n",
      "\n",
      "ELEVATED REVERSE T3 LEVEL:\n",
      "\n",
      "A high or high normal rT3 level may inhibit the action of T3.\n",
      "\n",
      "Elevated rT3 may therefore lead to symptoms of hypothyroidism even if levels of TSH, T4\n",
      "& T3 are adequate.\n",
      "\n",
      "Treatment Considerations:\n",
      "\n",
      "Consider T3 therapy\n",
      "Assess and treat iron, selenium, iodine and zinc\n",
      "\n",
      "THYROID AUTO-Abs\n",
      "\n",
      "THYROID PEROXIDASE Ab. 9.0 0.0 - 35.0 [U/mL e pS\n",
      "ANTITHYROGLOBULIN Ab. 12.9 0.0-115 [U/mL @ ||\n",
      "TSH RECEPTOR AB 0.8 0.0-1.8\n",
      "\n",
      "Tests ordered: TSHA,ESR,HBA1C,INSF,LDH,MG,PHOS,URAT,FBE,IS,FATS,LFT,FGLU,LIP,UEC, TFA,ITTCOM,Corca\n",
      "Pro,eGFR,UECom,GLUCom,IMPEI,GHBCOM,VITD,THAB,CFee, HOMA\n",
      "(“) Result outside normal reference range (H) Result is above upper limit of reference rang (L) Result is below lower limit of reference range\n",
      "\f",
      "\n",
      "------------------------------------- End record ----------------------------------\n",
      "\n",
      "\n",
      "\n",
      "------------------------------------- Start record --------------------------------\n",
      "ilaverty Pathology Report resus\n",
      "\n",
      "pathology ENQUIRIES\n",
      "\n",
      "removed \n",
      "removed\n",
      "2019\n",
      "Phone\n",
      "DOB Age 50 years Sex\n",
      "Re‘ bycopyto INTELLIGENT, SCREENING” Collect date 18/01/2024 _Labref  ggggggggggg\n",
      "Coliecttime gggggggg  Yourref ggggggggg\n",
      "Reported 18/01/202X 05:13 PM\n",
      "\n",
      "Tests requested SOM, HOR, AND, PRL, COR, MBA\n",
      "\n",
      "Clinica. notes\n",
      "\n",
      "~ Ce Se ee ee a ne eee\n",
      "\n",
      "INSULIN-LIKE GROWTH FACTOR-1 (IGF-1)\n",
      "Specimen Type: Serum\n",
      "IGF-1 (Somatomedin C) 37 nmol/L (10-32)\n",
      "\n",
      "Insulin-like growth factor 1 (IGF1) and insulin-like growth\n",
      "factor-binding protein 3 (IGFBP3) measurements can be used to assess\n",
      "growth hormone (GH) excess or deficiency. For all applications, IGF1\n",
      "measurement has generally been shown to have superior diagnostic\n",
      "accuracy. In particular, for the diagnosis and follow-up of acromegaly\n",
      "and gigantism, IGFBP3 measurement adds little extra diagnostic\n",
      "information.\n",
      "\n",
      "Elevated IGF1 levels support the diagnosis of acromegaly or gigantism in\n",
      "individuals with appropriate symptoms or signs. In successfully treated\n",
      "patients, levels should be within the reference interval, ideally within\n",
      "\n",
      "the lower third.\n",
      "\n",
      "SERUM HORMONE PROFILE\n",
      "Specimen Type: Serum\n",
      "\n",
      "Request Date FSH LH PROG E2(ATEL) E2(BECK) LH/FSH\n",
      "Number Collected IU/L = IU/L nmol/L pmol/L pmol/L Ratio\n",
      "26777050 18 Jan 24 <1 <0.1 <1 296\n",
      "Reference Ranges FSH LH PROG E2(ATEL)\n",
      "Males < 60 yrs <7 <7 0.9-3.9 <150\n",
      "\n",
      "> 60 yrs <14 <11 0.9-3.9 <150\n",
      "PLEASE NOTE:\n",
      "\n",
      "'E2 (ATEL)' - Oestradiol by Siemens Atellica assay\n",
      "'E2 (BECK)' - Oestradiol by Beckman Access assay\n",
      "\n",
      "SERUM ANDROGENS\n",
      "\n",
      "Total Testosterone (Siemens) 39.2 nmol/L (8.3-29)\n",
      "Sex Hormone Binding Globulin 34 nmol/t (11-71)\n",
      "DHEAS 4.4  umol/L (3.0-10)\n",
      "Calculated Free Testosterone 977.4 pmol/L (255.0-725.0)\n",
      "\n",
      "1 of 2\n",
      "\n",
      "M\n",
      "\n",
      "ORCPA\n",
      ", WwW\n",
      "\n",
      "SURGERY\n",
      "USE\n",
      "\n",
      "ars\n",
      "eta\n",
      "\n",
      "Na Pw ta\n",
      "\f",
      "\n",
      "OA Uy Wy\"\n",
      "\n",
      "\n",
      "\n",
      " + INTELUGENT, SCREENING\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "IMTELLIGENT. SCREEMING\n",
      "\n",
      "Pathology Report — Resutts\n",
      "\n",
      "ENQUIRIES\n",
      "\n",
      "\n",
      "\n",
      "2 er\"\n",
      "\n",
      "ree\n",
      "\n",
      "“7G\n",
      "\n",
      "ww te\n",
      "Ch, Ot t3°8\n",
      "\n",
      "Ch Ire\n",
      "\n",
      "removed \n",
      "\n",
      "\n",
      "MS4/ 2919\n",
      "\n",
      "02/06/1973 AG? SO yeas ad\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "REL ES  128401/2024 05 13 PIA\n",
      "\"ESS OQ ALES SOM, HOR AND. PRL. COR, MBA\n",
      "Cf Lt OWS OS\n",
      "PROLACTIN\n",
      "\n",
      "Specimen Type: Serum\n",
      "Request Date Prolactin\n",
      "Mumsber Collected mIU/L\n",
      "\n",
      "Ref Range (46-458)\n",
      "267778658 18/01/24 135\n",
      "\n",
      "4\n",
      "SERUM CORTISOL\n",
      "Time 68:58\n",
      "Cortisol 459 nmol/L\n",
      "AM Reference Interval 120-620 nmol/L\n",
      "SERUM CHEMISTRY\n",
      "\n",
      "Specimen Type: Serus\n",
      "Haes@olysis Mil\n",
      "Icterus Nil\n",
      "Lipaesia Wil\n",
      "Albumin 42 g/L (38-50)\n",
      "\n",
      "2 of 2\n",
      "\n",
      " \n",
      "\n",
      "1A\n",
      "s\n",
      "@hRCPA\n",
      "\n",
      "ae owl\n",
      "\n",
      " \n",
      "\n",
      "N\n",
      "\n",
      "MATA\n",
      "\f",
      "\n",
      "------------------------------------- End record ----------------------------------\n",
      "\n",
      "\n",
      "\n",
      "------------------------------------- Start record --------------------------------\n",
      "AUSTRALIAN LABORATORY 3427-18703 Referred: 02/04/19\n",
      "\n",
      "removed\n",
      "removed\n",
      "removed 15:55\n",
      "removed\n",
      "\n",
      " \n",
      "\n",
      "removed\n",
      "\n",
      "\n",
      "\\\n",
      "\n",
      "removed \n",
      "\n",
      "Ph:  Sex :Female\n",
      "\n",
      "Clinical Notes:\n",
      "\n",
      "BIOCHEMISTRY\n",
      "7\n",
      "4 PANCREATIC STUDIES SPECIMEN: SERUM\n",
      "uJ\n",
      "“ Coll. Date: 02/04/2019\n",
      "Oo Coll. Time: 17:30\n",
      "= Request No: 4499603 Ref. Range Units\n",
      "5 Amylase 75 (25 - 120) U/L\n",
      "ome Lipase 203 (70 - 390) U/L\n",
      "Amylase test performed on Siemens Advia/Attelica analyser\n",
      "Lipase test performed on Siemens Dimension analyser\n",
      "HAEMATOLOGY SPECIMEN: WHOLE BLOOD\n",
      "Date: 28/03/19 02/04/19 (#Refers to current\n",
      "Coll. Time: 16:15 17:30 result only)\n",
      "Lab Number: 4499762 #4499603\n",
      "HAEMOGLOBIN 116 144 (115 - 165) g/L\n",
      "RBC 3.87 4.76 (3.80 - 5.50)x1022/L\n",
      "PCV 0.36 0.43 (0.35 - 0.47)\n",
      "MCV 92 91 (80 - 99) £L\n",
      "MCH 30.0 30.3 (27.0 - 32.0)pg\n",
      "- MCHC 326 332 (310 - 360) g/L\n",
      "fo) x RDW 11.9 12.0 (11.0 - 15.0)%\n",
      "tT wcec 7.8 9.5 (4.0 - 11.0) x109/L\n",
      "6 Neutrophils 4.9 6.3 (2.0 - 8.0) x109/L\n",
      "ra Lymphocytes 2.1 2.2 (1.0 - 4.0) x109/L\n",
      "o Monocytes 0.7 0.9 (< 1.1) x107/L\n",
      "re) Eosinophils < 0.1 < 0.1 (< 0.6) x109/L\n",
      "= Basophils 0.0 0.0 (< 0.3) x107/L\n",
      "< PLATELETS 179 212. (150 - 450) x109/L\n",
      "ESR 2 (< 21) mm/h\n",
      "#4499603 : The red cell, white cell and platelet parameters are within\n",
      "normal limits.\n",
      "fi LFT-R, ECU-R, FBE-R, UMC-R, LSE-R, AML-R\n",
      "N CC Drs: WEGMAN. Page: 1 of 3\n",
      "\n",
      "   \n",
      "\n",
      "v) eT AA ix OT\n",
      "er aa a\n",
      "\n",
      "a a — a on ‘oo. eo\n",
      "\n",
      "     \n",
      "\n",
      "ARIA LO LO\n",
      "\n",
      "All Tests Complete\n",
      "\f",
      "\n",
      "AUSTRALIAN LABORATORY 3427-18703 Referred: 02/04/19\n",
      "\n",
      "removed\n",
      "iIniCalaDS sez vierm Tested: 02/04/19\n",
      "removed 15:55\n",
      "removed\n",
      "\n",
      "removed\n",
      "\n",
      "\n",
      "\\\n",
      "\n",
      "removed 2022\n",
      "\n",
      "Ph:  Sex _: Female\n",
      "\n",
      "Clinical Notes:\n",
      "\n",
      "GENERAL CHEMISTRY SPECIMEN: SERUM\n",
      "\n",
      "\" Date: 28/03/19 02/04/19\n",
      "\n",
      ". Time: 16:15 17:30\n",
      "Request: 4499762 4499603\n",
      "\n",
      ": Sodium 141 143. (135 - 145) = mmol/L\n",
      "\n",
      "- Potassium * 5.4 - 5.3 (3.5 - 5.2) mmol/L\n",
      "\n",
      "Chloride 107 104 (95 - 110) mmol/L\n",
      "\n",
      "y Bicarbonate 26 29 (22 - 32) mmol/L\n",
      "Urea 3.2 2.9 (2.5 - 8.0) mmol/L\n",
      "Creatinine 75 73 (45 - 90) umol/L\n",
      "eGFR > 90 > 90 (> 59) mL/min/1.73m2\n",
      "Calcium 2.33 (2.15 - 2.55) mmol/L\n",
      "Adj .Ca 2.29 (2.15 - 2.55) mmol/L\n",
      "Phosphate 1.25 (0.75 - 1.50) mmol/L\n",
      "T.Protein 68 72 (60 - 82) g/L\n",
      "Albumin 43 46 (35 - 50) g/L\n",
      "Globulin 25 26 (23 - 39) g/L\n",
      "ALP 41 40 (30 - 120) U/L\n",
      "Bilirubin 6 5 (< 25) umol /L\n",
      "GGT 7 13 (< 51) U/L\n",
      "AST 18 35 (< 41) U/L\n",
      "ALT 12 32 (< 41) U/L\n",
      "\n",
      "4499603 Specialist management noted.\n",
      "\n",
      "oy BIOCHEMISTRY\n",
      ". PANCREATIC STUDIES SPECIMEN: SERUM\n",
      "> Coll. Date: 02/04/2019\n",
      "; Coll. Time: 17:30\n",
      "Request No: 4499603 Ref. Range Units\n",
      "Amylase 75 (25 - 120) U/L\n",
      "\n",
      "Lipase 203 (70 - 390) U/L\n",
      "\n",
      "Amylase test performed on Siemens Advia/Attelica analyser\n",
      "Lipase test performed on Siemens Dimension analyser\n",
      "\n",
      "LFT-R,ECU-R, FBE-R, UMC-R, LSE-R,AML-R\n",
      "CC Drs: WEGMAN. Page: 2 of 3\n",
      "MS HARLOT AMYLASE RUM All Tests Complete\n",
      "\n",
      "_— -_ —_ —. ee\n",
      "\n",
      "                \n",
      "\n",
      "a —),o~ a\n",
      "7 es\n",
      "\f",
      "\n",
      "AUSTRALIAN LABORATORY 3427-18703 Referred: 02/04/19\n",
      "\n",
      "removed\n",
      "removed\n",
      "removed 15:55\n",
      "removed\n",
      "\n",
      "removed\n",
      "\n",
      "\n",
      "\\\n",
      "\n",
      "removed 2022\n",
      "\n",
      "Ph:  Sex :Female\n",
      "\n",
      "Clinical Notes:\n",
      "\n",
      "MICROBIOLOGY SPECIMEN: Mid Stream Urine\n",
      "+ CHEMISTRY\n",
      "- PH: 7.0 Protein: Nil Glucose: Nil Blood: Nil\n",
      ". MICROSCOPY\n",
      "= * Leucocytes 75 x 10°/L (< 10)\n",
      "Erythrocytes < 10 x 10°/L (< 10)\n",
      "< Epithelial Cells ++\n",
      "a CULTURE\n",
      "No significant growth.\n",
      "om\n",
      ">\n",
      "@\n",
      "@\n",
      "|\n",
      "2\n",
      "e LFT-R, ECU-R, FBE-R, UMC-R, LSE-R, AML-R\n",
      "P CC Drs: WEGMAN. Page: 3 of 3\n",
      "\n",
      "  \n",
      "\n",
      "Mi TAP LOT AMYLASE, SE All Tests Complete\n",
      "\n",
      "        \n",
      "\n",
      "“ut emnrn to gem 87 “a wa a, al a ee, a ae te rT ane [il ante oe a, ee a ie a “Pr OMA ot Wa} i; on ie\n",
      "\f",
      "\n",
      "AUSTRALIAN LABORATORY 3427-3420 Referred: 27/03/19\n",
      "\n",
      "@Clinicalabs wav PT Oa: Byes\n",
      "\n",
      "Tel:1300 134 111 Printed: 04/04/19 15:57\n",
      "Batch: 13054 1\n",
      "\n",
      "removed\n",
      "\n",
      "\n",
      "\\\n",
      "\n",
      "removed 2022\n",
      "\n",
      "Ph:  Sex : Female\n",
      "\n",
      "Clinical Notes:\n",
      "\n",
      "SEROLOGY\n",
      "t CALPROTECTIN SPECIMEN: FAECES\n",
      ", Calprotectin 49 ug/g (< 50)\n",
      "\n",
      "Interpretative Guide:\n",
      "\n",
      "Normal : <50 ug/g\n",
      "7 Mild inflammation: 51-200 ug/g\n",
      "Active inflammation: >200 ug/g\n",
      "\n",
      "This test is performed using the DiaSorin Liaison XL Calprotectin\n",
      "assay.\n",
      "\n",
      "IMMUNOLOGY SPECIMEN: SERUM\n",
      "\n",
      "ds-DNA ANTIBODIES\n",
      "(ELiA assay) < 10 IU/mL (< 10) (Equivocal: 10 - 15)\n",
      "\n",
      "As of 15/07/2011 ds-DNA antibodies are screened by E1liA assay.\n",
      "Positive EliA are confirmed by Modified Farr assay.\n",
      "Reference: F Fiegel et al: Lupus(2010) 19: 957-964\n",
      "\n",
      "A Antico et al: Lupus(2010) 19: 906-912\n",
      "\n",
      "2)... The following results on this sample have been reported in detail, and\n",
      "are reproduced here in abbreviated form for your convenience.\n",
      "\n",
      "ANTINUCLEAR ANTIBODIES\n",
      "\n",
      ". Anti-nuclear Antibody titre : < 160 (< 160)\n",
      "\n",
      "So\n",
      "\n",
      "7 FPC-R, CPT-R, FMC-R, CDI-R, TFT-R, PO4-R, LFT-R, ECU-R, CA-R, IS-R, FBE-R, ESR-R, TTG-\n",
      "CC Drs: BOBBA, WEGMAN. Page: 1 of 7\n",
      "\n",
      "        \n",
      "\n",
      "Mi 5 HARP TLOTT) DS-DNA ANTIBODIES\n",
      "\n",
      "Som mae\n",
      "\n",
      "        \n",
      "\n",
      "_ — a a — Pi ote tiee a Oa ‘ NA eN A a, rm A nn a\n",
      "\f",
      "\n",
      "AUSTRALIAN LABORATORY 3427-18703 Referred: 27/03/19\n",
      "\n",
      "removed\n",
      "INICAIADS sci vism Tested: 28/03/19\n",
      "Tel:1300 134 111 Printed: 04/04/19 15:57\n",
      "Batch: 13054 2\n",
      "\n",
      "removed\n",
      "\n",
      "\n",
      "\\\n",
      "\n",
      "removed 2022\n",
      "\n",
      "Ph:  Sex : Female\n",
      "\n",
      "Clinical Notes:\n",
      "\n",
      "MOLECULAR BIOLOGY\n",
      "\n",
      "* FAECAL PCR SPECIMEN: FAECES\n",
      "Norovirus Gl Not Detected\n",
      "= Norovirus G2 Not Detected\n",
      "Rotavirus A Not Detected\n",
      "= ** Adenovirus DETECTED\n",
      "; ** Enteric Adenovirus 40/41 DETECTED\n",
      "a Astrovirus Not Detected\n",
      ". Enterovirus Not Detected\n",
      "Sapovirus Not Detected\n",
      "Bocavirus Not Detected\n",
      "\n",
      "Cryptosporidium species Not Detected\n",
      "\n",
      "Giardia intestinalis Not Detected\n",
      "\n",
      "Entamoeba histolytica Not Detected\n",
      "** Dientamoeba fragilis DETECTED\n",
      "\n",
      "Blastocystis hominis Not Detected\n",
      "\n",
      "The pathogenicity of Dientamoeba fragilis is not well defined. Symptoms\n",
      "usually include abdominal discomfort, diarrhoea, nausea, poor weight\n",
      "gain and fatigue.\n",
      "\n",
      ") *. Testing performed by DNA amplification using Genetic Signatures\n",
      "EasyScreen Enteric assay.\n",
      "\n",
      "# Target is still under evaluation.\n",
      "2 SPECIMEN RECEPTION\n",
      "\n",
      ". Specimens to follow:\n",
      "\n",
      "CPT: FAECAL CALPROTECTIN Received\n",
      "FMC: FAECES MICRO/CULTURE Received\n",
      "FPC: FAECAL PCR - COMBINED Received\n",
      "CDI: C. DIFFICILE TOXIN TEST Received\n",
      "\n",
      "FPC-R, CPT-R, FMC-R, CDI-R, TFT-R, PO4-R, LFT-R, ECU-R, CA-R, IS-R, FBE-R, ESR-R, TTG-\n",
      "CC Drs: BOBBA, WEGMAN. Page: 2 of 7\n",
      "Vi HART Ct) ) OL LOW PANEL\n",
      "\n",
      "—_™~ os\n",
      "\n",
      "             \n",
      "\n",
      " \n",
      "\f",
      "\n",
      "AUSTRALIAN LABORATORY 3427-18703 Referred: 27/03/19\n",
      "\n",
      "@linicalabs we ern ese e/e3/as\n",
      "\n",
      "Tel:1300 134 111 Printed: 04/04/19 15:57\n",
      "Batch: 13054 3\n",
      "\n",
      "removed\n",
      "\n",
      "\n",
      "\\\n",
      "\n",
      "removed 2022\n",
      "\n",
      "Ph:  Sex _: Female\n",
      "\n",
      "Clinical Notes:\n",
      "\n",
      "MICROBIOLOGY SPECIMEN: FAECES 1.\n",
      ") DATE OF COLLECTION: 28/03/19\n",
      "’ TIME OF COLLECTION: 1615 h\n",
      "MACROSCOPY:\n",
      "\n",
      "Unformed specimen.\n",
      "\n",
      "MICROSCOPY:\n",
      "= Fat globules(neutral fats) detected.\n",
      "; Leucocytes not detected. Erythrocytes not detected.\n",
      "a No parasite ova detected.\n",
      "Enteric viruses and protozoa: refer to PCR report.\n",
      "\n",
      "C. difficile toxin (A+B): Not Detected\n",
      "\n",
      "CULTURE:\n",
      "Salmonella, Shigella, Campylobacter and Yersinia NOT isolated.\n",
      "\n",
      "HAEMATOLOGY SPECIMEN: WHOLE BLOOD\n",
      "Date: 28/03/19 (#Refers to current\n",
      "Coll. Time: 16:15 result only)\n",
      "Lab Number: #4499762\n",
      "HAEMOGLOBIN 116 (115 - 165) g/L\n",
      "RBC 3.87 (3.80 - 5.50)x1022/L\n",
      ", PCV 0.36 (0.35 - 0.47)\n",
      " . MCV 92 (80 - 99) fL\n",
      ") MCH 30.0 (27.0 - 32.0)pg\n",
      ", MCHC 326 (310 - 360) g/L\n",
      ", RDW 11.9 (11.0 - 15.0)%\n",
      "2 wcc 7.8 (4.0 - 11.0) x109/L\n",
      ". Neutrophils 4.9 (2.0 - 8.0) x109/L\n",
      ", Lymphocytes 2.1 (1.0 - 4.0) x109/L\n",
      "Monocytes 0.7 (< 1.1) x107/L\n",
      "Eosinophils < 0.1 (< 0.6) x10?/L\n",
      "Basophils 0.0 (< 0.3) x109/L\n",
      "PLATELETS . 179 (150 - 450) x109/L\n",
      "ESR 2 (< 21) mm/h\n",
      "\n",
      "#4499762 : The red cell, white cell and platelet parameters are within\n",
      "normal limits.\n",
      "\n",
      "} FPC-R, CPT-R, FMC-R, CDI-R, TFT-R, PO4-R, LFT-R, ECU-R, CA-R, IS-R, FBE-R, ESR-R, TTG-\n",
      "; CC Drs: BOBBA, WEGMAN. Page: 3 of 7\n",
      "vi} by Ae Tf ory el AA IVE TC DTC a <i\n",
      "\n",
      "et — oo. oe - _ _—— re oe on\n",
      "\n",
      "        \n",
      "\n",
      "   \n",
      "\n",
      "a Pn\n",
      "\f",
      "\n",
      "AUSTRALIAN LABORATORY 3427-18703 Referred: 27/03/19\n",
      "\n",
      "removed\n",
      "removed\n",
      "Tel:1300 134 111 Printed: 04/04/19 15:57\n",
      "Batch: 13054 4\n",
      "\n",
      " \n",
      "\n",
      "removed\n",
      "\n",
      "\n",
      "\\\n",
      "\n",
      "removed 2022\n",
      "\n",
      "Ph:  Sex :Female\n",
      "\n",
      "Clinical Notes:\n",
      "\n",
      "GENERAL CHEMISTRY SPECIMEN: SERUM\n",
      "og\n",
      "~ Date: 28/03/19\n",
      "md Time: 16:15\n",
      "i Request : 4499762\n",
      "O See ee ee ee age a ye\n",
      "J Sodium 141 (135 - 145) mmol/L\n",
      "<4 Potassium * 5.4 (3.5 - 5.2) mmol/L\n",
      "- Chloride 107 (95 - 110) mmol/L\n",
      "ss Bicarbonate 26 (22 - 32) mmol /L\n",
      "Urea 3.2 (2.5 - 8.0) mmol/L\n",
      "Creatinine 75 (45 - 90) umol /L\n",
      "eGFR > 90 (> 59) mL/min/1.73m2\n",
      "Calcium 2.33 (2.15 - 2.55) mmol/L\n",
      "Adj .Ca 2.29 (2.15 - 2.55) mmol/L\n",
      "Phosphate 1.25 (0.75 - 1.50) mmol/L\n",
      "T. Protein 68 (60 - 82) g/L\n",
      "Albumin 43 (35 - 50) g/L\n",
      "Globulin 25 (23 - 39) g/L\n",
      "ALP 41 (30 - 120) U/L\n",
      "Bilirubin 6 (< 25) umol/L\n",
      "GGT 7 (< 51) U/L\n",
      "AST 18 (< 41) U/L\n",
      "ALT 12 (< 41) U/L\n",
      "4499762 Specialist management noted.\n",
      "=\n",
      ". a BIOCHEMISTRY\n",
      "im\n",
      "“ C REACTIVE PROTEIN (CRP) SPECIMEN: SERUM\n",
      "o Date Time Lab No. CRP Units Ref. Range\n",
      "O ee ee ee ew ewe ee eee em ee ee ee ee we ew we ee ee ee ee wm ne a rae\n",
      "28/03/19 16:15 4499762 < 0.7 mg/L (< 3.0)\n",
      "7 In the setting of infection, CRP levels >100 mg/L are supportive of\n",
      "bacterial rather than viral aetiology.\n",
      "Note results from this CRP assay should not be used for cardiac risk\n",
      "assessment. Please request the high sensitivity assay (nhsCRP) instead.\n",
      "i FPC-R, CPT-R, FMC-R, CDI-R, TFT-R, PO4-R, LFT-R, ECU-R, CA-R, IS-R, FBE-R, ESR-R, TTG-\n",
      "x CC Drs: BOBBA, WEGMAN. Page: 4 of 7\n",
      "\n",
      "          \n",
      "\n",
      "ud (\"HH Ak et\n",
      "\n",
      "= -REACTIVE PROTEIN\n",
      "\f",
      "\n",
      "AUSTRALIAN LABORATORY 3427-18703 Referred: 27/03/19\n",
      "\n",
      "removed\n",
      "removed\n",
      "Te1l:1300 134 111 Printed: 04/04/19 15:57\n",
      "Batch: 13054 5\n",
      "\n",
      "  \n",
      "\n",
      "removed\n",
      "\n",
      "\n",
      "NORTH BONDI 2026 [Ref :P71655 |LVL 10, 1 NBWLAND ST\n",
      "\n",
      "removed 2022\n",
      "\n",
      "Ph:  Sex : Female\n",
      "\n",
      "Clinical Notes:\n",
      "\n",
      "- BIOCHEMISTRY\n",
      "a\n",
      "4 GLUCOSE\n",
      "oc\n",
      "= Date Time Lab# Collection Type Specimen Glucose\n",
      "Oo mmol/L\n",
      "fe) (mmol /L)\n",
      "TR TO RR RR RHE Ee eee\n",
      "S. 28/03/19 16:15 4499762 Not stated serum 5.0\n",
      "| ed\n",
      "= 4\n",
      "Oe 4499762 INTERPRETATION\n",
      "Normal random glucose.\n",
      "Glucose Reference Ranges\n",
      "Random 3.0 - 6.9 mmol/L\n",
      "Fasting 3.0 - 5.4 mmol/L\n",
      "1 Hour post prandial 3.0 - 11.0 mmol/L\n",
      "2 Hour post prandial 3.0 - 7.7 mmol/L\n",
      "Specimen Legend:\n",
      "fl-ox = Fluoride oxalate, serum = Serum, np = Non-Preserved\n",
      "BIOCHEMISTRY\n",
      "IRON STUDIES SPECIMEN: SERUM\n",
      "Date: 28/03/19\n",
      "Lab Number: 4499762\n",
      "MCN eee eee eee ee ee ee en ne ee ere\n",
      "oc\n",
      "ro) Tron 12.7 (10.0 - 30.0) umol/L\n",
      "rT Transferrin * 1.93 (2.10 - 3.80) g/L\n",
      "a Saturation 26 (15 - 45) %\n",
      "ro Ferritin * 22 (30 - 200) ug/L\n",
      "g\n",
      "< 4499762 Specialist management noted.\n",
      "_\n",
      "c\n",
      "a.\n",
      ";\n",
      ": FPC-R, CPT-R, FMC-R, CDI-R, TFT-R, PO4-R, LFT-R, ECU-R, CA-R, IS-R, FBE-R, ESR-R, TTG-\n",
      "a CC Drs: BOBBA, WEGMAN. Page: 5 of 7\n",
      "\n",
      "   \n",
      "    \n",
      "   \n",
      "\n",
      "       \n",
      "\n",
      "AR LOTT) RON MA x\n",
      "\n",
      " \n",
      "\n",
      "—~ eo. ~~ — =, Py —“~ — = eal — con r4 o— oy\n",
      "\f",
      "\n",
      " \n",
      " \n",
      "    \n",
      "\n",
      "a?\n",
      "\n",
      "     \n",
      "   \n",
      "\n",
      "  \n",
      "  \n",
      "  \n",
      " \n",
      " \n",
      "\n",
      " \n",
      "   \n",
      "\n",
      "n\n",
      "Pcie, 7 1! —_ ' ' —— ‘ 3 oie\n",
      "\n",
      "ett EL ®\n",
      "\n",
      "    \n",
      "\n",
      ". . ly el oft um a.\n",
      "eee LABORATORY 3427-3420 Referred: 27/03/29\n",
      "removed\n",
      "removed\n",
      "Tel:1300 134 111 Printed: 04/04/19 15:57\n",
      "Batch: 13054 6\n",
      "removed\n",
      "\n",
      "\\\n",
      "removed 2022\n",
      "Ph:  Sex :Female\n",
      "\n",
      "Clinical Notes:\n",
      "\n",
      "BIOCHEMISTRY\n",
      ",\n",
      "’ VITAMIN B12 AND FOLATE SPECIMEN: SERUM/BLOOD\n",
      ",\n",
      "| Date: 28/03/19\n",
      "= Time: 16:15\n",
      "Lab Number: 4499762\n",
      ">\n",
      "0 na nnn ne nnn enn nnn nn nn nnn nnn rn nn nnn nnn enn nnn nnn nn nner rr rc crerrrcsccee\n",
      "; Vitamin B12 > 1476 pmol/L\n",
      "a Folate 15.7 nmol/L\n",
      "4499762 Normal B12 and folate results.\n",
      "RANGES B12 Serum Folate Red Cell Folate\n",
      "Normal > 180 > 10.0 > 450\n",
      "Equivocal 150 - 180 5.0 - 10.0 350 - 450\n",
      "Deficient < 150 < 5.0 < 350\n",
      "Vitamin B12 and Folate analyses are performed on the Siemens Centaur.\n",
      "ENDOCRINOLOGY\n",
      "THYROID FUNCTION TEST SPECIMEN: SERUM\n",
      "2) \\_. Date: 28/03/19\n",
      "Coll. Time: 16:15\n",
      ": Lab Number: 4499762\n",
      "° TSH 1.09 (0.50 - 5.00) mIU/L\n",
      "®\n",
      "4499762 Normal TSH level.\n",
      "IMMUNOLOGY SPECIMEN: SERUM\n",
      "ANTINUCLEAR ANTIBODIES\n",
      "Anti-nuclear Antibody titre : < 160 (< 160)\n",
      "Negative ANA is not associated with SLE.\n",
      "The following results on this sample have been reported in detail, and\n",
      "| are reproduced here in abbreviated form for your convenience.\n",
      "A\n",
      "z FPC-R, CPT-R, FMC-R, CDI-R, TFT-R, PO4-R, LFT-R, ECU-R, CA-R, IS-R, FBE-R, ESR-R, TIG-\n",
      "2 CC Drs: BOBBA, WEGMAN. Page: 6 of 7\n",
      "\n",
      "    \n",
      "      \n",
      "\n",
      "4 Mi mY Fe HARTA a ANTI -Ni EAR ANTIBODIES\n",
      "\n",
      "|e any OP | .\n",
      "\n",
      "           \n",
      "\n",
      "CLIRTHER Si |\n",
      "\n",
      "   \n",
      "\n",
      "aa. me PIO la . N aN Na oyun ATIE\n",
      "\f",
      "\n",
      " \n",
      "\n",
      "AUSTRALIAN LABORATORY 3427-3420 Referred: 27/03/19\n",
      "\n",
      " \n",
      "\n",
      " \n",
      "\n",
      "@ ®@ ; . a\n",
      "removed\n",
      "removed\n",
      "Tel:1300 134 111 Printed: 04/04/19 's5:57\n",
      "Baté) 13054 7\n",
      "removed\n",
      "\n",
      "\\\n",
      "removed 2022\n",
      "Ph:  sex :Female\n",
      "Clinical Notes:\n",
      "IMMUNOLOGY SPECIMEN: SERUM\n",
      "COELIAC DISEASE ANTIBODIES\n",
      "REFERENCE RANGES\n",
      "Normal Low Mod. Strong\n",
      "Deamidated Gliadin IgG < 20 CU (< 20) (20-50) (51-80) (> 80)\n",
      "Tissue Transglutaminase IgA < 20 CU (< 20) (20-50) (51-80) (> 80)\n",
      "\\ INTERPRETATION\n",
      "Coeliac disease is unlikely provided the patient has not been on a gluten\n",
      "free diet.\n",
      "TTG IgA and DGP IgG antibodies are tested by chemiluminescent\n",
      "immunoassay (CIA) .\n",
      "Results are reported in chemiluminescent units (CU).\n",
      "eee Oe -\n",
      "YM\n",
      "\n",
      "FPC-R, CPT-R, FMC-R, CDI-R, TFT-R, PO4-R, LFT-R, ECU-R, CA-R, IS-R, FBE-R, ESR-R, TTG-\n",
      "\n",
      "CC Drs: BOBBA, WEGMAN.\n",
      "Vd ea BA be OT)\n",
      "\n",
      "Page: 7 of 7\n",
      "ANTI-NUCLEAR ANTIBODIES\n",
      "\n",
      "‘tae, aan cent ae eG ire ioe “, VR AA Sr, ae Oe Ny ProabkiraAagc oT (ATIC Gey fae.\n",
      "\n",
      "     \n",
      "\n",
      "eon allanol\n",
      "\n",
      "4\n",
      "-\n",
      "\n",
      "The,\n",
      "\n",
      "ah\n",
      "\n",
      "J\n",
      "\n",
      "me\n",
      "\n",
      "nage\n",
      "\n",
      " \n",
      "\n",
      "   \n",
      "  \n",
      "\n",
      "    \n",
      "\f",
      "\n",
      "------------------------------------- End record ----------------------------------\n",
      "\n",
      "\n",
      "\n",
      "------------------------------------- Start record --------------------------------\n",
      "Patient Name;, \n",
      "Patient Address: \n",
      "\n",
      "D.O.B: 24/09/1932 Gender: F\n",
      "Medicare No.: THI No.:\n",
      "Lab. Reference:  Provider: \n",
      "Addressee:\n",
      "Date Requested: 10/12/2018 Date Performed: 10/12/2018\n",
      "Date Collected: 10/12/2018 Complete: Final\n",
      "Specimen:\n",
      "\n",
      "Subject(Test Name): THYROID FUNCTION TEST (TFT-0)\n",
      "Clinical Information:\n",
      "\n",
      "Clinical Notes : For review with elevated prolactin\n",
      "\n",
      "THYROID PROFILE\n",
      "\n",
      "\n",
      "Specimen Type: Serum\n",
      "\n",
      "TSH (0.5-4.0) miIU/L 0.73 0.82 0.64 0.46\n",
      "\n",
      "FT4 (10-20) pmol/L 15 13 13\n",
      "\n",
      "FT3 (3.5-6.0) pmol/L 4.8\n",
      "\n",
      "Please note marginally low TSH. This may be a variation of normal or may\n",
      "be an early phase of thyroid dysfunction. Suggest follow up review with\n",
      "TFTs as clinically appropriate.\n",
      "\n",
      "Requested Tests : VBF, UMM, TFT, TAA, PRL, PTH, ESR, CRP, CEA, C19, C15, 125, MBA, FE, FBE, DVI,\n",
      "COR\n",
      "\f",
      "\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "Date Requested: 10/12/2018 Date Performed: 10/12/2018\n",
      "\n",
      "Date Collected: 10/12/2018 Complete: Final\n",
      "\n",
      "Specimen:\n",
      "\n",
      "Subject(Test Name): VITAMIN D (DVI-0)\n",
      "Clinical Information:\n",
      "\n",
      "Clinical Notes : For review with elevated prolactin\n",
      "VITAMIN D\n",
      "\n",
      "Serum 25(0OH) Vitamin D 108 nmol/L\n",
      "\n",
      "Suggested decision limits for Vitamin D status:\n",
      "\n",
      "Sufficiency 51 -200 nmol/L\n",
      "Mild deficiency 25 - 50 nmol/L\n",
      "Marked deficiency < 25 nmol/L\n",
      "Toxicity >250 nmol/L\n",
      "\n",
      "References: Vitamin:-D and health in adults in Australia and New Zealand:\n",
      "Position Statement. MJA 2012 June 18; 196(11),686-687.\n",
      "\n",
      "Requested Tests : VBF, UMM, TFT*, TAA, PRL, PTH, ESR, CRP, CEA, C19, C15, 125, MBA, FE, FBE,\n",
      "DVI, COR\n",
      "\f",
      "\n",
      "Patient Name:\n",
      "Patient Address:\n",
      "\n",
      "D.O.B:\n",
      "Medicare No.: THI No.:\n",
      "- Lab. Reference: \n",
      "Addressee: \n",
      "Date Requested: 10/12/2018 Date Performed: 10/12/2018\n",
      "Date Collected: 10/12/2018 Complete: Final\n",
      "Specimen:\n",
      "\n",
      "Subject(Test Name): SERUM CORTISOL (COR-0)\n",
      "Clinical Information:\n",
      "\n",
      "Clinical Notes : For review with elevated prolactin\n",
      "SERUM CORTISOL\n",
      "\n",
      "Time 15:36\n",
      "Cortisol 188 nmol/L\n",
      "\n",
      "PM Reference Interval 100-400 nmol/L\n",
      "\n",
      "Requested Tests : VBF, UMM, TFT*, TAA, PRL, PTH, ESR, CRP, CEA, C19, C15, 125, MBA, FE, FBE,\n",
      "DVI*, COR\n",
      "\f",
      "\n",
      "Patient Name: \n",
      "Patient Address; \n",
      "\n",
      "D.O.B: \n",
      "Medicare No.: \n",
      "Lab. Reference: \n",
      "Addressee:  Referred by; \n",
      "Date Requested: 10/12/2018 Date Performed: 10/12/2018\n",
      "Date Collected: 10/12/2018 Complete: Final\n",
      "Specimen:\n",
      "\n",
      "Subject(Test Name): IRON STUDIES (FE-0)\n",
      "Clinical Information:\n",
      "\n",
      "Clinical Notes : For review with elevated prolactin\n",
      "\n",
      "IRON STUDIES\n",
      "\n",
      "Request Number \n",
      "Date Collected 12 Sep 17 8 Nov 17 30 Apr 18 10 Dec 18\n",
      "Time Collected 10:45 14:45 12:05 15:36\n",
      "\n",
      "Specimen Type: Serum\n",
      "\n",
      "Iron (10-30) umol/L 40 33 21 27\n",
      "\n",
      "T' ferrin (32-48) umol/L 24 20 21 22\n",
      "\n",
      "T. Sat. (13-45) % 85 84 51 63\n",
      "\n",
      "Ferritin (30-400) ug/L 63 110 115 44\n",
      "\n",
      "Monitoring of haemochromatosis noted. Current guidelines recommend\n",
      "maintaining ferritin levels between 50 and 100 ug/L. (AASLD. Hepatology\n",
      "2011; 54:328-43).\n",
      "\n",
      "Requested Tests’: VBF, UMM, TFT*, TAA, PRL, PTH, ESR, CRP, CEA, C19, C15, 125, MBA, FE, FBE,\n",
      "DVI*, COR*\n",
      "\f",
      "\n",
      "Patient Name; \n",
      "\n",
      "Patient Address: \n",
      "\n",
      "D.O.B: 24/09/1932 Gender: F\n",
      "Medicare No.:  IHI No.:\n",
      "\n",
      "Lab. Reference: \n",
      "Addressee: \n",
      "\n",
      "Date Requested: 10/12/2018 Date Performed:, 10/12/2018\n",
      "\n",
      "Date Collected: 10/12/2018 | Complete: Final\n",
      "Specimen:\n",
      "Subject(Test Name): PARATHYROID HORMONE (PTH-0)\n",
      "\n",
      "Clinical Information:\n",
      "\n",
      "Clinical Notes :\n",
      "\n",
      "For review with elevated prolactin\n",
      "\n",
      "PARATHYROID HORMONE\n",
      "\n",
      "Request Number\n",
      "Date Collected\n",
      "\n",
      "11744628 14721343\n",
      "30 Apr 18 10 Dec 18\n",
      "\n",
      "Time Collected 12:05 15:36\n",
      "Specimen Type: Plasma\n",
      "iPTH (1.5-9.9) pmol/L 8.3 9.0\n",
      "\n",
      "Results do not suggest a parathyroid disorder.\n",
      "\n",
      "Requested Tests :\n",
      "\n",
      "DVI*, COR*\n",
      "\n",
      "VBF, UMM, TFT*, TAA, PRL, PTH, ESR, CRP, CEA, C19, C15, 125, MBA, FE*\n",
      "\n",
      "e\n",
      "\n",
      "FBE,\n",
      "\f",
      "\n",
      "Patient Name: \n",
      "Patient Address: \n",
      "\n",
      "D.O.B: 24/09/1932 Gender: F\n",
      "Medicare No.:  THI No.:\n",
      "Lab. Reference: \n",
      "Addressee: \n",
      "Date Requested: 10/12/2018 Date Performed: 10/12/2018\n",
      "Date Collected: 10/12/2018 Complete: Final\n",
      "Specimen:\n",
      "\n",
      "Subject(Test Name): THYROID AUTOANTIBODIES (TAA-0)\n",
      "Clinical Information:\n",
      "\n",
      "Clinical Notes : For review with elevated prolactin\n",
      "THYROID AUTOANTIBODIES\n",
      "Specimen Type: Serum\n",
      "\n",
      "Anti-Thyroglobulin Abs (Immulite) 110 TU/mL (< 41)\n",
      "Anti-Thyroidal Peroxidase Abs 332 U/mL (< 60)\n",
      "\n",
      "Over 90% of patients with autoimmune thyroiditis show moderate to high\n",
      "levels of Anti-Thyroidal Peroxidase Abs (anti-TPO) with\n",
      "Anti-Thyroglobulin Abs (anti-Tg) also present in about 90% of such\n",
      "patients. Up to 75% of patients with Graves' hyperthyroidism show\n",
      "increased anti-TPO with anti-Tg present in 50-60%. Low levels of both\n",
      "anti-TPO and anti-Tg may be found in up to 10% of \"normal\" asymptomatic\n",
      "adults. In most cases of autoimmune thyroid disease increased anti-TPO is\n",
      "the predominant finding although a small proportion of patients show a\n",
      "predominant increase in anti-Tg.\n",
      "\n",
      "Requested Tests : VBF, UMM, TFT*, TAA, PRL, PTH*, ESR, CRP, CEA, C19, C15, 125, MBA, FE*, FBE,\n",
      "DVI*, COR*\n",
      "\f",
      "\n",
      "Patient Name: \n",
      "Patient Address: \n",
      "\n",
      "D.O.B: 24/09/1932 Gender: F\n",
      "Medicare No.:  THI No.:\n",
      "Lab. Reference: \n",
      "Addressee: \n",
      "Date Requested: 10/12/2018 Date Performed: 10/12/2018\n",
      "Date Collected: 10/12/2018 Complete: Final\n",
      "Specimen:\n",
      "\n",
      "Subject(Test Name): SERUM C.E.A (CEA-0)\n",
      "Clinical Information:\n",
      "\n",
      "Clinical Notes : For review with elevated prolactin\n",
      "\n",
      "SERUM CARCINO EMBRYONIC ANTIGEN\n",
      "\n",
      "Request Number 28473096 10809027 11744628 14721343\n",
      "Date Collected 7 Jun 17 8 Nov 17 30 Apr 18 10 Dec 18\n",
      "Time Collected 12:55 14:45 12:05 15:36\n",
      "\n",
      "CEA (Bayer) (< 2.6) ug/L 4.2 3.4 4.1 3.4\n",
      "\n",
      "CEA concentrations may increase due to benign conditions, including liver\n",
      "disease, renal failure, pancreatitis and inflammatory bowel disease.\n",
      "Smoking may also increase CEA concentrations. CEA measurement has been\n",
      "recommended for the ongoing monitoring and surveillance of patients with\n",
      "known neoplasia. The test has insufficient sensitivity and specificity\n",
      "for diagnostic utility.\n",
      "\n",
      "Requested Tests : VBF, UMM, TFT*, TAA*, PRL, PTH*, ESR, CRP, CEA, C19, C15, 125, MBA, FE*, FBE,\n",
      "DVI*, COR*\n",
      "\f",
      "\n",
      "Patient Name; \n",
      "\n",
      "Patient Address: \n",
      "D.O.B: 24/09/1932 Gender: F\n",
      "Medicare No.:  IHI No.:\n",
      "\n",
      "Lab. Reference: \n",
      "Addressee: \n",
      "\n",
      "Date Requested: 10/12/2018 Date Performed: 10/12/2018\n",
      "\n",
      "Date Collected: 10/12/2018 Complete: Final\n",
      "\n",
      "Specimen:\n",
      "\n",
      "Subject(Test Name): CARBOHYDRATE ANTIGEN 19-9 (C19-0)\n",
      "Clinical Information:\n",
      "\n",
      "Clinical Notes : For review with elevated prolactin\n",
      "\n",
      "SERUM CANCER ANTIGEN 19.9\n",
      "\n",
      "Request Number 28473096 10809027 11744628 14721343\n",
      "Date Collected 7 Jun 17 8 Nov 17 30 Apr 18 10 Dec 18\n",
      "Time Collectd 12:55 14:45 12:05 15:36\n",
      "CA-19.9 (< 37) U/mL 10 5.0 6.0 7.0\n",
      "\n",
      "(Bayer Centaur)\n",
      "\n",
      "Requested Tests : VBF, UMM, TFT*, TAA*, PRL, PTH*, ESR, CRP, CEA*, C19, C15, 125, MBA, FE*, FBE,\n",
      "DVI*, COR*\n",
      "\f",
      "\n",
      "Patient Name: \n",
      "Patient Address: \n",
      "\n",
      "D.O.B: 24/09/1932 Gender: F\n",
      "Medicare No.:  THI No.:\n",
      "Lab. Reference: \n",
      "Addressee: DRINNA LIEB Referred by: DR. INNA LIEB\n",
      "Date Requested: 10/12/2018 Date Performed: 10/12/2018\n",
      "Date Collected: 10/12/2018 Complete: Final\n",
      "Specimen:\n",
      "\n",
      "Subject(Test Name): CANCER ANTIGEN 125 (125-0)\n",
      "Clinical Information:\n",
      "\n",
      "Clinical Notes : For review with elevated prolactin\n",
      "\n",
      "SERUM CANCER ANTIGEN 125\n",
      "\n",
      "Request Number 28473096 10809027 11744628 14721343\n",
      "Date Collected 7 Jun 17 8 Nov 17 30 Apr 18 10 Dec 18\n",
      "Time Collected 12:55 14:45 12:05 15:36\n",
      "\n",
      "CA125 (< 35) U/mL 17 11 15 13\n",
      "\n",
      "Requested Tests : VBF, UMM, TET*, TAA*, PRL, PTH*, ESR, CRP, CEA*, C19*, C15, 125, MBA, FE*\n",
      "FBE, DVI*, COR*\n",
      "\f",
      "\n",
      "Patient Name; \n",
      "Patient Address: \n",
      "\n",
      "D.O.B: 24/09/1932 Gender: F\n",
      "Medicare No.:  THI No.:\n",
      "Lab. Reference: \n",
      "Addressee: \n",
      "Date Requested: 10/12/2018 Date Performed: 10/12/2018\n",
      "Date Collected: 10/12/2018 | Complete: Final\n",
      "Specimen:\n",
      "\n",
      "Subject(Test Name): B12, FOLATE, R.C.FOLATE (VBF-0)\n",
      "Clinical Information:\n",
      "\n",
      "Clinical Notes : For review with elevated prolactin\n",
      "\n",
      "VITAMIN Bl2 AND FOLATE STUDIES\n",
      "\n",
      "Request Number 28473096 10809027 11744628 14721343\n",
      "Date Collected 7 Jun 17 8 Nov 17 30 Apr 18 10 Dec 18\n",
      "Time Collected 12:55 14:45 12:05 15:36\n",
      "\n",
      "B12 (301-740) pmol/L 252 408 860 537\n",
      "\n",
      "Active B12 (> 36) pmol/L > 128\n",
      "\n",
      "Serum Folate (> 9.0)nmol/L 23.1 23.2 25.0 33.6\n",
      "\n",
      "Folate Interpretation:\n",
      "\n",
      "| | DEFICIENCY | BORDERLINE | SUFFICIENCY |\n",
      "| pre nen enn nee pon--- +--+ $----------~-------+- $o-ee--------- |\n",
      "| Serum Folate: | <4.5 nmol/L | 4.5 - 9.0 nmol/L | >9.0 nmol/L |\n",
      "| --------------- $------------- $-—----------------- $o---+-------- |\n",
      "| RBC Folate: | <340 nmol/L | 340 - 570 nmol/L | >570 nmol/L |\n",
      "\n",
      "Serum Folate Assay:\n",
      "In the absence of recent oral intake, a serum folate >9.0 nmol/L\n",
      "effectively rules out folate deficiency.\n",
      "\n",
      "Please note that Medicare requirements for folate testing reflect current\n",
      "best practice. Red cell folate will be reserved for patients with\n",
      "borderline values for serum folate (between 4.5 and 9.0 nmol/L.)\n",
      "\n",
      "Requested Tests : VBF, UMM, TFT*, TAA*, PRL, PTH*, ESR, CRP, CEA*, C19*, C15, 125*, MBA, FE*\n",
      "FBE, DVI*, COR*\n",
      "\f",
      "\n",
      "Patient Name: \n",
      "Patient Address: \n",
      "\n",
      "D.O.B: 24/09/1932 Gender: F\n",
      "Medicare No.:  THI No.:\n",
      "Lab. Reference: \n",
      "Addressee: \n",
      "Date Requested: 10/12/2018 Date Performed: 10/12/2018\n",
      "Date Collected: 10/12/2018 Complete: Final\n",
      "Specimen:\n",
      "\n",
      "Subject(Test Name): SERUM CHEMISTRY (MBA-0)\n",
      "Clinical Information:\n",
      "\n",
      "Clinical Notes : For review with elevated prolactin\n",
      "\n",
      "SERUM CHEMISTRY\n",
      "\n",
      "Request Number 10289756 10809027 11744628 14721343\n",
      "Date Collected 12 Sep 17 8 Nov 17 30 Apr 18 10 Dec 18\n",
      "Time Collected 10:45 14:45 12:05 15:36\n",
      "\n",
      "Specimen Type: Serum\n",
      "\n",
      "Haemolysis Nil Nil Nil Nil\n",
      "\n",
      "Icterus Nil Nil Nil Nil\n",
      "\n",
      "Lipaemia Nil Nil Nil Nil\n",
      "\n",
      "Na (135-145) mmol/L 140 142 138 138\n",
      "\n",
      "K (3.6-5.4) mmol/L 4.5 4.0 3.8 4.2\n",
      "\n",
      "Cl (95-110) mmol/L 106 108 101 106\n",
      "HCO3 (22-32) mmol/L 24 24 26 25\n",
      "An Gap (10-20) mmol/L 14 14 15 11\n",
      "Urea (3.0-10.0) mmol/L 6.5 5.7 2.3 6.7\n",
      "Creat (45-90) umol/L 45 55 40 55\n",
      "eGFR mL/min/1.73m*2 88 83 > 90 81\n",
      "Urate (0.14-0.36) mmol/L 0.28 0.14 0.21\n",
      "Bili (< 15) umol/L 13 13 10 9\n",
      "AST (< 35) U/L 25 26 26 19\n",
      "ALT (< 30) U/L 20 17 17 13\n",
      "GGT (< 35) U/L 11 12 12 12\n",
      "Alk Phos (30-115) U/L 65 60 70 62\n",
      "Protein (60-82) g/L 69 63 68 65\n",
      "Albumin (36-48) g/L 41 39 43 41\n",
      "Glob (20-39) g/L 28 24 25 24\n",
      "Ca (2.10-2.60) mmol/L 2.39 2.43 2.41 2.41\n",
      "Corr Ca (2.10-2.60) mmol/L 2.43 2.51 2.41 2.45\n",
      "PO4 (0.75-1.50) mmol/L 1.00 1.95 1.01 1.24\n",
      "CPK (< 211) U/L 160 64 68\n",
      "Amylase (< 121) U/L 55 57 73\n",
      "Lipase (6-70) U/L 32 29 38\n",
      "Mg (0.70-1.10) mmol/L 0.82 0.86 0.90\n",
      "\n",
      "eGFR values between 60 and 89 mL/min/1.73m2 should be interpreted with\n",
      "caution. These results are only consistent with CKD in the presence of\n",
      "other evidence such as microalbuminuria, proteinuria or haematuria.\n",
      "Ref:Lamb EJ etal in Ann Clin Biochem 2005; 42:321-345.\n",
      "\n",
      "Requested Tests : VBF*, UMM, TFT*, TAA*, PRL, PTH*, ESR, CRP, CEA*, C19*, C15, 125*, MBA, FE*\n",
      "FBE, DVI*, COR*\n",
      "\f",
      "\n",
      "Patient Name: \n",
      "Patient Address: \n",
      "\n",
      "D.O.B: 24/09/1932 Gender: F\n",
      "Medicare No.:  IHI No.:\n",
      "Lab. Reference: \n",
      "Addressee: DRINNA LIEB Referred by: DR. INNA LIEB\n",
      "Date Requested: 10/12/2018 Date Performed: 10/12/2018\n",
      "Date Collected: 10/12/2018 Complete: Final\n",
      "Specimen:\n",
      "\n",
      "Subject(Test Name): SERUM PROLACTIN (PRL-0)\n",
      "Clinical Information:\n",
      "\n",
      "Clinical Notes : For review with elevated prolactin\n",
      "\n",
      "PROLACTIN\n",
      "\n",
      "Specimen Type: Serum\n",
      "\n",
      "Request Date Prolactin\n",
      "Number Collected mIU/L\n",
      "\n",
      "Ref Range (40-570)\n",
      "\n",
      "24623334 01/11/16 114\n",
      "28473096 07/06/17 84\n",
      "10289756 12/09/17 90\n",
      "10809027 08/11/17 121\n",
      "12519902 25/05/18 78\n",
      "14721343 10/12/18 92\n",
      "\n",
      "Requested Tests : VBF*, UMM, TFT*, TAA*, PRL, PTH*, ESR, CRP, CEA*, C19*, C15, 125*, MBA, FE*,\n",
      "FBE, DVI*, COR*\n",
      "\f",
      "\n",
      "Subject(Test Name):\n",
      "\n",
      "Patient Name:\n",
      "Patient Address:\n",
      "\n",
      "D.O.B: 24/09/1932\n",
      "\n",
      "Medicare No.:\n",
      "Lab. Reference:\n",
      "Addressee:\n",
      "\n",
      "Date Requested\n",
      "Date Collected\n",
      "Specimen\n",
      "\n",
      "\n",
      "\n",
      ": 10/12/2018\n",
      ": 10/12/2018\n",
      "\n",
      "Clinical Information:\n",
      "\n",
      "Clini\n",
      "\n",
      "cal Notes :\n",
      "\n",
      "Request Number\n",
      "\n",
      "Date\n",
      "Time\n",
      "Spe\n",
      "CRP\n",
      "\n",
      "Requ\n",
      "FBE,\n",
      "\n",
      "Collected\n",
      "Collected\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "Date Performed:\n",
      "\n",
      "C-REACTIVE PROTEIN (CRP-0)\n",
      "\n",
      "For review with elevated prolactin\n",
      "\n",
      "C-REACTIVE PROTEIN\n",
      "10809027 11744628\n",
      "\n",
      "7 Jun 17\n",
      "\n",
      "cimen Type: Serum\n",
      "\n",
      "(< 6.0)\n",
      "\n",
      "ested Tests\n",
      "DVI*, COR*\n",
      "\n",
      "mg/L\n",
      "\n",
      ": VBF*, UMM,\n",
      "\n",
      "28473096\n",
      "12:55\n",
      "< 4.0\n",
      "\n",
      "TFET*, TAA*,\n",
      "\n",
      "8 Nov 17\n",
      "\n",
      "14:45\n",
      "< 4.0\n",
      "\n",
      "PRL*, PTH*,\n",
      "\n",
      "‘ Gender:\n",
      "\n",
      "F\n",
      "\n",
      "JHI No.:\n",
      "\n",
      "Provider:\n",
      "Referred by:\n",
      "\n",
      "Laverty Pathology\n",
      "DR. INNA LIEB\n",
      "\n",
      "10/12/2018\n",
      "\n",
      "Complete: Final\n",
      "\n",
      "30 Apr 18\n",
      "\n",
      "12:05\n",
      "\n",
      "< 4.0\n",
      "\n",
      "14721343\n",
      "10 Dec 18\n",
      "15:36\n",
      "\n",
      "< 4.0\n",
      "\n",
      "ESR, CRP, CEA*, C19*,\n",
      "\n",
      "C15,\n",
      "\n",
      "125*,\n",
      "\n",
      "MBA*,\n",
      "\n",
      "FE*\n",
      "\n",
      "t\n",
      "\f",
      "\n",
      "Patient Name: \n",
      "Patient Address: \n",
      "\n",
      "D.O.B: 24/09/1932 Gender: F\n",
      "Medicare No.:  THI No.:\n",
      "Lab. Reference: \n",
      "Addressee: \n",
      "Date Requested: 10/12/2018 Date Performed: 10/12/2018\n",
      "‘Date Collected: 10/12/2018. Complete: Final\n",
      "Specimen:\n",
      "\n",
      "Subject(Test Name); CARBOHYDRATE ANTIGEN 15-3 (C15-0)\n",
      "Clinical Information:\n",
      "\n",
      "Clinical Notes : For review with elevated prolactin\n",
      "\n",
      "SERUM CANCER ANTIGEN 15.3\n",
      "\n",
      "Request Number 28473096 10809027 11744628 14721343\n",
      "\n",
      "Date Collected 7 Jun 17 8 Nov 17 30 Apr 18 10 Dec 18\n",
      "Time Collected 12:55 14:45 12:05 15:36\n",
      "CA-15.3 (< 39) U/mL 17 12 20 18\n",
      "\n",
      "(Bayer Centaur)\n",
      "\n",
      "Requested Tests : VBF*, UMM, TET*, TAA*, PRL*, PTH*, ESR, CRP*, CEA*, C19*, C15, 125*, MBA*\n",
      "FE*, FBE, DVI*, COR*\n",
      "\f",
      "\n",
      "Patient Name: \n",
      "Patient Address: \n",
      "\n",
      "D.O.B: 24/09/1932 Gender: F\n",
      "Medicare No.;  THI No.:\n",
      "Lab. Reference: \n",
      "Addressee: \n",
      "Date Requested: 10/12/2018 Date Performed: 10/12/2018\n",
      "Date Collected: 10/12/2018 Complete: Final\n",
      "Specimen:\n",
      "\n",
      "Subject(Test Name): URINE MICRO/CULTURE (UMM-0)\n",
      "Clinical Information:\n",
      "\n",
      "Clinical Notes : For review with elevated prolactin\n",
      "\n",
      "URINE EXAMINATION\n",
      "\n",
      "Specimen Midstream\n",
      "CHEMISTRY ; MICROSCOPY\n",
      "\n",
      "pH 6.5 Leucocytes 5 x10°6 /L (< 10)\n",
      "Protein nil Erythrocytes 46 x10*6 /L (< 10)\n",
      "Glucose nil Epithelial cells 2 x10°6 /L (< 10)\n",
      "Blood +\n",
      "\n",
      "A urine with these results is not usually infected. Although culture has\n",
      "been performed, a further report will only be issued if the culture is\n",
      "positive.\n",
      "\n",
      "Haematuria noted.\n",
      "\n",
      "Requested Tests : VBF*, UMM, TFT*, TAA*, PRL*, PTH*, ESR, CRP*, CEA*, C19*, Ci5*, 125*, MBA*\n",
      "FE*, FBE, DVI*, COR*\n",
      "\f",
      "\n",
      "Patient Name; \n",
      "Patient Address; \n",
      "\n",
      "D.O.B: 24/09/1932 Gender: F\n",
      "Medicare No.:  THI No.:\n",
      "Lab. Reference: \n",
      "Addressee: DRINNA LIEB Referred by: DR. INNA LIEB\n",
      "Date Requested: 10/12/2018 Date Performed: 10/12/2018\n",
      "Date Collected: 10/12/2018 Complete: Final\n",
      "Specimen:\n",
      "\n",
      "Subject(Test Name): E.S.R (ESR-0)\n",
      "Clinical Information:\n",
      "\n",
      "Clinical Notes : For review with elevated prolactin\n",
      "\n",
      "HAEMATOLOGY\n",
      "\n",
      "Request Number 10289756 10809027 11744628 14721343\n",
      "Date Collected 12 Sep 17 8 Nov 17 30 Apr 18 10 Dec 18\n",
      "Time Collected 10:45 14:45 12:05 15:36\n",
      "Specimen Type: EDTA\n",
      "\n",
      "ESR (< 30) mm/hr 2 2 5 2\n",
      "\n",
      "Requested Tests : VBF*, UMM*, TFT*, TAA*, PRL*, PTH*, ESR, CRP*, CEA*, C19*, C15*, 125*, MBA*\n",
      "FE*, FBE, DVI*, COR*\n",
      "\f",
      "\n",
      "Patient Name: \n",
      "\n",
      "Patient Address; \n",
      "D.O.B: 24/09/1932 Gender: F\n",
      "Medicare No.:  IHI No.:\n",
      "\n",
      "Lab. Reference: \n",
      "Addressee: \n",
      "\n",
      "Date Requested: 10/12/2018 Date Performed: 10/12/2018\n",
      "\n",
      "Date Collected: 10/12/2018 Complete: Final\n",
      "\n",
      "Specimen:\n",
      "\n",
      "Subject(Test Name): HAEMATOLOGY (FBE-0)\n",
      "Clinical Information:\n",
      "\n",
      "Clinical Notes : For review with elevated prolactin\n",
      "\n",
      "HAEMATOLOGY\n",
      "Request Number 10289756 10809027 11744628 14721343\n",
      "Date Collected 12 Sep 17 8 Nov 17 30 Apr 18 10 Dec 18\n",
      "Time Collected 10:45 14:45 12:05 15:36\n",
      "Specimen Type: EDTA\n",
      "Hb (115-165) g/L 141 125 141 130\n",
      "Hct (0.34-0.47) 0.43 0.37 0.41 0.40\n",
      "RCC (3.9-5.8) x10°12 /L 4.1 3.7 4.0 3.8\n",
      "MCV (79-99) £L 104 103 102 105\n",
      "MCH (27-34) pg 35 34 35 35\n",
      "MCHC (320-360) g/L 332 334 347 329\n",
      "RDW (10.0-17.0) $% 12.9 13.0 12.6 12.8\n",
      "WBC (4.0-11.0) *10°9 /L 7.2 6.4 6.4 5.6\n",
      "Neut (2.0-7.5) x10°9 /L 4.4 3.2 4.2 2.7\n",
      "Lymph (1.0-4.0) x10*°9 /L 1.8 2.1 1.3 1.9\n",
      "Mono (0.2-1.0) x10*9 38/L 0.7 0.7 0.6 0.7\n",
      "Eos (< 0.7) x10*9) «=/L 0.2 0.3 0.3 0.2\n",
      "Baso (< 0.2) x10*°9 /L 0.1 0.1 0.1 0.1\n",
      "Plat (150-400) x10*9 /L 195 176 200 202\n",
      "\n",
      "HAEMATOLOGY: Macrocytic blood picture.\n",
      "\n",
      "Requested Tests : VBF*, UMM*, TFT*, TAA*, PRL*, PTH*, ESR*, CRP*, CEA*, C19*, C15*, 125*, MBA*,\n",
      "FE*, FBE, DVI*, COR*\n",
      "\f",
      "\n",
      "------------------------------------- End record ----------------------------------\n",
      "\n",
      "\n",
      "\n",
      "------------------------------------- Start record --------------------------------\n",
      "iilaverty -—- Pathology Report resuits @RCPA\n",
      "\n",
      "pathology ENQUIRIES tet cramer NF\n",
      "removed\n",
      "removed\n",
      "removed\n",
      "Phone\n",
      "D.O.B XXXXXXXXXXX\n",
      "\n",
      "\n",
      "\n",
      "removed\n",
      "\n",
      "Reported 18/01/2024 05:13 PM\n",
      "\n",
      "Tests requested SOM, HOR, AND, PRL, COR, MBA\n",
      "\n",
      "Clinical notes\n",
      "\n",
      "INSULIN-LIKE GROWTH FACTOR-1 (IGF-1)\n",
      "Specimen Type: Serum\n",
      "IGF-1 (Somatomedin C) 37 nmol/L (10-32)\n",
      "\n",
      "Insulin-like growth factor 1 (IGF1) and insulin-like growth\n",
      "factor-binding protein 3 (IGFBP3) measurements can be used to assess\n",
      "growth hormone (GH) excess or deficiency. For all applications, IGF1\n",
      "measurement has generally been shown to have superior diagnostic\n",
      "accuracy. In particular, for the diagnosis and follow-up of acromegaly\n",
      "and gigantism, IGFBP3 measurement adds little extra diagnostic\n",
      "information.\n",
      "\n",
      "Elevated IGF1 levels support the diagnosis of acromegaly or gigantism in\n",
      "individuals with appropriate symptoms or signs. In successfully treated\n",
      "patients, levels should be within the reference interval, ideally within\n",
      "the lower third.\n",
      "\n",
      "SERUM HORMONE PROFILE\n",
      "Specimen Type: Serum\n",
      "\n",
      "Request Date FSH LH PROG E2(ATEL) E2(BECK) LH/FSH\n",
      "Number Collected IU/L IU/L nmol/L pmol/L pmol/L Ratio\n",
      "26777050 18 Jan 24 <1 <0.1 < 1 296\n",
      "Reference Ranges FSH LH PROG E2(ATEL)\n",
      "Males < 60 yrs <7 <7 0.9-3.9 <150\n",
      "\n",
      "> 60 yrs <14 <11 0.9-3.9 <150\n",
      "\n",
      "PLEASE NOTE:\n",
      "'E2 (ATEL)' - Oestradiol by Siemens Atellica assay\n",
      "'E2 (BECK)' - Oestradiol by Beckman Access assay\n",
      "\n",
      "SURGERY\n",
      "USE\n",
      "SERUM ANDROGENS Normal\n",
      "Total Testosterone (Siemens) 39.2 nmol/L (8.3-29)\n",
      "Sex Hormone Binding Globulin 34 nmol/L (11-71) No ActionFile\n",
      "DHEAS 4.4  umol/L (3.0-10) |\n",
      "Calculated Free Testosterone 977.4 pmol/L (255.0-725.0) nen\n",
      "Make\n",
      "Appoint.\n",
      "Further Tests\n",
      "Notes\n",
      "Required\n",
      "Speak\n",
      "with Dr\n",
      "\n",
      "1 of ? On Correct\n",
      "\n",
      "Treatment\n",
      "\n",
      "LAV_RTE001_AV3_07/23\n",
      "\f",
      "\n",
      "hl laverty Pathology Report Resutts ORCPA mm\n",
      "\n",
      "ENQUIRIES Accredited for compliance win» WA\n",
      "\n",
      "pathology NPAAC Standards and ISO 15189 pon RE ans ei\n",
      "removed\n",
      "removed\n",
      "removed\n",
      "removed \n",
      "Phone\n",
      "D.O.B XXXXXXXXXXX Mm\n",
      "\n",
      "\n",
      "\n",
      "removed\n",
      "\n",
      "Reported 18/01/2024 05:13 PM\n",
      "Tests requested SOM, HOR, AND, PRL, COR, MBA\n",
      "Clinical notes\n",
      "PROLACTIN\n",
      "Specimen Type: Serum\n",
      "Request Date Prolactin\n",
      "Number Collected mIU/L\n",
      "\n",
      "Ref Range (40-450)\n",
      "\n",
      "26777050 18/01/24 135\n",
      "\n",
      "SERUM CORTISOL\n",
      "\n",
      "Time 08:50\n",
      "Cortisol 459 nmol/L\n",
      "\n",
      "AM Reference Interval 120-620 nmol/L\n",
      "\n",
      "SERUM CHEMISTRY\n",
      "Specimen Type: Serum\n",
      "\n",
      "Haemolysis Nil\n",
      "Icterus Nil\n",
      "Lipaemia Nil\n",
      "Albumin 42 g/L (38-50)\n",
      "\n",
      "SURGERY\n",
      "USE\n",
      "\n",
      "Normal\n",
      "No ActionFile\n",
      "Patient\n",
      "\n",
      "Notified\n",
      "\n",
      "Make\n",
      "Appoint.\n",
      "\n",
      "Further Tests\n",
      "Notes\n",
      "Required\n",
      "\n",
      "Speak\n",
      "with Dr\n",
      "\n",
      "? of ? On Correct\n",
      "\n",
      "Treatment\n",
      "\n",
      "LAV_RTE001_AV3_07/23\n",
      "\f",
      "\n",
      "------------------------------------- End record ----------------------------------\n",
      "\n",
      "\n",
      "\n"
     ]
    }
   ],
   "source": [
    "for record in records:\n",
    "    print(\"------------------------------------- Start record --------------------------------\")\n",
    "    f = open(record, \"r\")\n",
    "    print(f.read()) \n",
    "    print(\"------------------------------------- End record ----------------------------------\")\n",
    "    print(\"\")\n",
    "    print(\"\")\n",
    "    print(\"\")\n",
    "#     break"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "e01c64c4",
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3 (ipykernel)",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.11.3"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
